{"meta":{"query_hash":"ac4ca2444aff","filters":{"venue":"Drugs in R&D"},"cohort_total":56,"direct_labels_cover":0,"predictions_cover":56,"exported":56,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ac4ca2444aff","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs+in+R%26D"},"results":[{"id":"W139570440","doi":"10.2165/00126839-200607020-00001","title":"Selective Phosphodiesterase (PDE)-4 Inhibitors","year":2006,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Neuroinflammation; Neuroprotection; Phosphodiesterase; Neuroscience; Disease; Medicine; Amyloid (mycology); Cyclic adenosine monophosphate; Microglia; Pharmacology; Alzheimer's disease; Psychology; Internal medicine; Biology; Enzyme; Inflammation; Biochemistry; Pathology; Receptor","score_opus":0.013165600289247858,"score_gpt":0.293421831570008,"score_spread":0.28025623128076016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W139570440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003500361,0.99428743,0.000040927534,0.000009632055,0.00081745937,0.00051435194,0.000040662042,0.000024873554,0.0039146156],"genre_scores_gemma":[0.00040573074,0.992777,0.000096924494,0.0000638309,0.0005593062,0.00015880409,0.0014103639,0.00006689749,0.0044611436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998277,0.0001432884,0.00054446526,0.0005807422,0.00015150578,0.0003029726],"domain_scores_gemma":[0.99922705,0.000028208875,0.00024791158,0.00038044187,0.000054189095,0.00006219287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018682318,0.00041411252,0.00069849787,0.00016782679,0.00006354424,0.00003435112,0.00017153821,0.00054867525,0.000015767308],"category_scores_gemma":[0.000039029117,0.00036090997,0.00034445856,0.00030493044,0.000072763156,0.000004409686,0.00010779738,0.00027262783,0.00005146357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004502009,0.00020359377,0.00014388972,0.0032798008,0.00014421658,0.000011814026,0.000110596484,0.000051298415,0.00005843299,0.00005375444,0.049263325,0.94663423],"study_design_scores_gemma":[0.0002775573,0.0000520271,0.00003116622,0.0013629253,0.00006953453,0.000013323809,0.000014890149,0.000003658863,0.00045075858,0.000020577761,0.9972969,0.00040664163],"about_ca_topic_score_codex":0.000056779198,"about_ca_topic_score_gemma":0.00007043795,"teacher_disagreement_score":0.94803363,"about_ca_system_score_codex":0.00011525868,"about_ca_system_score_gemma":0.00020603808,"threshold_uncertainty_score":0.9998843},"labels":[],"label_agreement":null},{"id":"W15991883","doi":"10.2165/00126839-200506040-00006","title":"Is there a Scottish road to socialism","year":2007,"lang":"en","type":"book-chapter","venue":"Drugs in R&D","topic":"Political and Economic history of UK and US","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Socialism; Political science; Economic geography; Geography; History; Law","score_opus":0.0513895762944489,"score_gpt":0.318495621233826,"score_spread":0.2671060449393771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W15991883","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001523432,0.0005718564,0.0000022617182,0.0023017575,0.0008369092,0.00015565012,0.000041611598,0.0000369845,0.99452955],"genre_scores_gemma":[0.014362332,0.00020132163,0.000049305705,0.0039995825,0.0012407661,0.0000049267633,0.000004266841,0.00002219794,0.9801153],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882454,0.000016780603,0.0002435135,0.00027782307,0.00020688586,0.00043048125],"domain_scores_gemma":[0.9994747,0.00004939476,0.000059061887,0.00014080269,0.000026193231,0.00024982454],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004946904,0.00015276678,0.0002824632,0.00012053282,0.00023691005,0.000035273944,0.00028144996,0.0004017422,0.0055575497],"category_scores_gemma":[0.000026682348,0.00017034692,0.0001422763,0.00002592788,0.00026239856,0.000050161263,0.000043058844,0.00025936036,0.0028719052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057881134,0.000009546798,0.000038361115,0.000008498975,0.000011738163,0.000012633732,0.02547828,1.1678041e-7,9.6495484e-8,0.88495445,0.04819739,0.04128311],"study_design_scores_gemma":[0.00007487499,0.000008043641,0.00018766371,0.00006948061,0.000006242506,1.519593e-7,0.0005147228,3.5535714e-7,4.7887954e-7,0.07980559,0.9191233,0.00020911843],"about_ca_topic_score_codex":0.006604245,"about_ca_topic_score_gemma":0.0064486763,"teacher_disagreement_score":0.8709259,"about_ca_system_score_codex":0.00045088233,"about_ca_system_score_gemma":0.00021887505,"threshold_uncertainty_score":0.9983686},"labels":[],"label_agreement":null},{"id":"W1976165878","doi":"10.2165/11593140-000000000-00000","title":"Impact of Respiratory Syncytial Virus","year":2011,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Respiratory viral infections research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Jewish General Hospital; Children's Hospital of Winnipeg; Mount Sinai Hospital","funders":"","keywords":"Palivizumab; Medicine; Transmission (telecommunications); Respiratory tract infections; Virus; Intensive care medicine; Disease; Infection control; Pediatrics; Health care; Respiratory system; Immunology; Internal medicine","score_opus":0.16643239077104025,"score_gpt":0.4867733928526308,"score_spread":0.32034100208159055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976165878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019021085,0.9764789,0.000002578392,6.707223e-7,0.00015665236,0.0010932607,0.000051531035,0.00003811093,0.020276187],"genre_scores_gemma":[0.00034343512,0.9986876,0.000031558655,0.000016260079,0.00025329285,0.0001490707,0.00002079758,0.00008978196,0.00040817895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973875,0.00039651198,0.0010144509,0.00042604568,0.00035744352,0.0004180116],"domain_scores_gemma":[0.99824893,0.00015953444,0.00031286967,0.0009480468,0.00014224574,0.00018837661],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007706957,0.0003909369,0.0021665867,0.0013549844,0.00002924995,0.000011515521,0.00029497975,0.0005349895,0.0011993307],"category_scores_gemma":[0.0003653185,0.0002845157,0.0010053313,0.0010458585,0.00021024875,0.000081327096,0.00014132488,0.0011225726,0.0005615611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006453449,0.00035409542,0.0009857434,0.01025604,0.00028346636,0.0000687862,0.00008133843,4.1331134e-7,0.000014333773,0.00012486304,0.0014362233,0.98633015],"study_design_scores_gemma":[0.00050725386,0.00081802503,0.0010601254,0.00861452,0.00026643637,0.000029450559,0.000004721755,9.4938423e-7,0.000020689327,0.000017314413,0.9884177,0.0002428186],"about_ca_topic_score_codex":0.00060462544,"about_ca_topic_score_gemma":0.000017420774,"teacher_disagreement_score":0.98698145,"about_ca_system_score_codex":0.0007340763,"about_ca_system_score_gemma":0.0019550167,"threshold_uncertainty_score":0.9999607},"labels":[],"label_agreement":null},{"id":"W1983697728","doi":"10.2165/11596340-000000000-00000","title":"Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Darunavir; Raltegravir; Ritonavir; Medicine; Maraviroc; Viral load; Regimen; Adverse effect; Internal medicine; Integrase inhibitor; Clinical endpoint; Gastroenterology; Virology; Pharmacology; Randomized controlled trial; Human immunodeficiency virus (HIV); Antiretroviral therapy","score_opus":0.042722759738994726,"score_gpt":0.290875164831624,"score_spread":0.24815240509262929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983697728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9508016,0.00009568496,0.0000014163627,0.00013572411,0.00022948942,0.00053848204,0.000004283546,0.00004695158,0.04814638],"genre_scores_gemma":[0.9946605,0.00006523075,0.0011058815,0.000049347997,0.00001737751,0.00010906536,0.000118805125,0.000021445958,0.0038523609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988166,0.000034143766,0.00027874348,0.00032408003,0.00020644836,0.00033998728],"domain_scores_gemma":[0.99950314,0.000037943562,0.00004915057,0.00026600307,0.000029034025,0.00011471642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007170171,0.00020471502,0.00030477418,0.00019118801,0.000039304217,0.000006570263,0.00008204192,0.00008704461,0.00054713007],"category_scores_gemma":[0.000028139248,0.00017065326,0.000059725928,0.00029551913,0.000058498346,0.000098167424,0.000030741994,0.00009648638,0.0003898131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016046276,0.002191548,0.8901406,0.0000120525465,0.000076688724,0.00020012494,0.066328935,5.1397234e-7,0.0000351503,0.00008339802,0.00030053937,0.039025836],"study_design_scores_gemma":[0.046201214,0.0011674431,0.93213516,0.00021464184,0.00009190747,0.0000037592151,0.006488275,0.00009906124,0.0038676306,0.0001330713,0.009116902,0.0004809037],"about_ca_topic_score_codex":0.00048259186,"about_ca_topic_score_gemma":0.00039337564,"teacher_disagreement_score":0.05984066,"about_ca_system_score_codex":0.00038462048,"about_ca_system_score_gemma":0.000093405426,"threshold_uncertainty_score":0.69590384},"labels":[],"label_agreement":null},{"id":"W1990684646","doi":"10.2165/00126839-200506010-00005","title":"Pharmacokinetics and Pilot Efficacy of???a Mesalazine Rectal Gel in Distal Ulcerative Colitis","year":2005,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada); University of Alberta; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ulcerative colitis; Mesalazine; Medicine; Pharmacokinetics; Gastroenterology; Internal medicine; Pharmacotherapy; Disease","score_opus":0.007117704362962512,"score_gpt":0.26424613722991114,"score_spread":0.25712843286694864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990684646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971101,0.0001727047,0.00001860055,0.0000798924,0.000049848917,0.00020768734,0.000049526563,0.000005466045,0.0023061319],"genre_scores_gemma":[0.9991473,0.00011098487,0.00025858314,0.000093558316,0.00012462994,0.000018325836,0.00005681546,0.000015372614,0.0001744306],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992083,0.000075984826,0.00022821619,0.0002215661,0.000084795014,0.00018118233],"domain_scores_gemma":[0.99969345,0.000019635017,0.000050524028,0.00014006614,0.00003150255,0.00006483807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014085951,0.00011637745,0.0001188741,0.000055374432,0.00001569467,0.000007745517,0.00008660195,0.000053999047,0.00002710464],"category_scores_gemma":[0.00006917252,0.00012496568,0.000027619435,0.0000684827,0.00010935602,0.0000047517115,0.000080187485,0.00008466619,0.000004279512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012052051,0.0027080574,0.19635016,0.00034159515,0.0001788199,0.00036232898,0.005144049,0.002303489,0.72484165,0.0025459577,0.0041980026,0.048973866],"study_design_scores_gemma":[0.0048997635,0.00017558718,0.90402037,0.00003861876,0.000014548873,0.0000074751474,0.000109580265,0.00060771103,0.08614617,0.000060120637,0.0036461146,0.00027393643],"about_ca_topic_score_codex":0.00001578159,"about_ca_topic_score_gemma":0.00026766254,"teacher_disagreement_score":0.7076702,"about_ca_system_score_codex":0.000023871711,"about_ca_system_score_gemma":0.0000498554,"threshold_uncertainty_score":0.5095953},"labels":[],"label_agreement":null},{"id":"W2002722147","doi":"10.2165/00126839-200607010-00003","title":"A Newly Synthesised Molybdenum/Ascorbic Acid Complex Alleviates Some Effects of Cardiomyopathy in Streptozocin-Induced Diabetic Rats","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Allison University","funders":"","keywords":"Ascorbic acid; Streptozocin; Internal medicine; Diabetes mellitus; Endocrinology; Diabetic cardiomyopathy; Medicine; Insulin; Chemistry; Streptozotocin; Heart failure; Cardiomyopathy; Food science","score_opus":0.008430378460796025,"score_gpt":0.2201597351369941,"score_spread":0.21172935667619808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002722147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262595,0.0006997443,0.0000029353268,0.00010301436,0.00007490782,0.00014058812,0.000024188244,0.00005669418,0.006271982],"genre_scores_gemma":[0.99930876,0.000022447202,0.00008702176,0.000044413628,0.00015410353,0.000072330455,0.00006508907,0.000038878065,0.00020693078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816686,0.000056639557,0.00056436553,0.00043043995,0.00032994794,0.00045172582],"domain_scores_gemma":[0.99888945,0.00033020976,0.00018772515,0.0004545056,0.00005015544,0.000087937806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017814685,0.00028334907,0.00056118105,0.00017119444,0.000039957642,0.000026102909,0.0003473661,0.00022195726,0.00019458505],"category_scores_gemma":[0.00015507045,0.0003105568,0.0001619195,0.00027994276,0.00007208209,0.00010048543,0.00007158852,0.000250706,0.00002196967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020108771,0.00019964247,0.017883971,0.0006942807,0.000026613458,0.000054424338,0.0004129588,0.00015055017,0.97943294,0.00011252924,0.00017333911,0.00083866366],"study_design_scores_gemma":[0.0015514751,0.000010674172,0.017299695,0.00026767448,0.000026620222,0.0000030263425,0.00027798236,0.00026663573,0.9791626,0.0007714511,0.00005978591,0.00030243438],"about_ca_topic_score_codex":0.0006696076,"about_ca_topic_score_gemma":0.00013090807,"teacher_disagreement_score":0.0066828397,"about_ca_system_score_codex":0.00019642817,"about_ca_system_score_gemma":0.000098178585,"threshold_uncertainty_score":0.9999347},"labels":[],"label_agreement":null},{"id":"W2011049230","doi":"10.2165/00126839-200809050-00002","title":"Applications of Metabolomics in Drug Discovery and Development","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Genome Alberta","keywords":"Metabolomics; Drug discovery; Drug development; Identification (biology); Biomarker discovery; Pharmaceutical industry; Data science; Computational biology; Drug; Computer science; Biochemical engineering; Medicine; Pharmacology; Bioinformatics; Biology; Proteomics; Engineering","score_opus":0.015038168381594233,"score_gpt":0.28750146908595287,"score_spread":0.27246330070435865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011049230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016839524,0.997036,0.0001320329,0.000004427471,0.00004756045,0.00043437694,0.000036575315,0.0000019997508,0.00062308676],"genre_scores_gemma":[0.00046594153,0.9966112,0.0020305011,0.000010106158,0.000045965604,0.0002629177,0.00016750967,0.000021444848,0.0003844331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988013,0.000052775507,0.00052319595,0.00036773484,0.00007916288,0.00017582496],"domain_scores_gemma":[0.99946785,0.000029731753,0.00019496861,0.00026250677,0.000018592353,0.00002636135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016968981,0.00022715403,0.0008762953,0.00022516694,0.000026217678,0.000007559761,0.00018207992,0.00014540597,0.0000014947988],"category_scores_gemma":[0.000026024456,0.00019860314,0.00009327477,0.00022872178,0.00008314006,0.0000026379387,0.00024230489,0.00013982094,0.0000017136695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008402571,0.00016013123,0.00032693654,0.0028524217,0.00019782236,0.0000020640302,0.00026430728,0.0000013668603,0.000065601074,0.0011952999,0.00035449528,0.99457115],"study_design_scores_gemma":[0.00015611692,0.000006197317,0.00007214838,0.00024525786,0.000025990763,0.0000056545787,0.000062166415,1.8925003e-7,0.0002145775,0.00002782589,0.9989924,0.00019151422],"about_ca_topic_score_codex":0.000024956264,"about_ca_topic_score_gemma":0.000088608955,"teacher_disagreement_score":0.99863786,"about_ca_system_score_codex":0.000025009978,"about_ca_system_score_gemma":0.0002030112,"threshold_uncertainty_score":0.80988014},"labels":[],"label_agreement":null},{"id":"W2014795914","doi":"10.1007/s40268-013-0030-8","title":"An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report","year":2013,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Waypoint Centre for Mental Health Care; University of Toronto","funders":"Eli Lilly and Company","keywords":"Olanzapine; Active ingredient; Dissolution; Excipient; Chromatography; Dosage form; Dissolution testing; Materials science; Pharmacology; Chemistry; Medicine; Biopharmaceutics Classification System; Schizophrenia (object-oriented programming)","score_opus":0.04067849629454533,"score_gpt":0.3935812172620812,"score_spread":0.35290272096753583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014795914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970161,0.0001886809,0.0009133587,0.0000634645,0.000118377306,0.00047599836,0.00008725067,0.000011199889,0.0011256147],"genre_scores_gemma":[0.9987488,0.000034419532,0.0006352661,0.000017855433,0.000015360565,0.000056083514,0.00028768193,0.000010009975,0.00019455882],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983321,0.00023681509,0.0008789567,0.0002153986,0.00015417449,0.00018259273],"domain_scores_gemma":[0.9987264,0.000277767,0.00046526457,0.0003125903,0.00016201075,0.000055962657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038814524,0.00013364332,0.0005400434,0.0006443027,0.00002289155,0.000002677928,0.00016049431,0.00015019666,0.00061872526],"category_scores_gemma":[0.00007335554,0.000118864715,0.00011102325,0.0008443548,0.00010122928,0.00023894671,0.00003642129,0.00020180756,0.0000033463828],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007301555,0.001662781,0.4234281,0.00016736642,0.00053500186,0.00001023744,0.0070488155,0.059690107,0.5008631,0.0011454924,0.00012388517,0.0045950105],"study_design_scores_gemma":[0.0015269589,0.00021813247,0.21829063,0.00006555984,0.0005946422,0.0000051535426,0.0024103418,0.46579364,0.30989677,0.0008321028,0.00013981655,0.0002262389],"about_ca_topic_score_codex":0.0006548842,"about_ca_topic_score_gemma":0.00016649213,"teacher_disagreement_score":0.40610355,"about_ca_system_score_codex":0.00007323801,"about_ca_system_score_gemma":0.000035588557,"threshold_uncertainty_score":0.67746073},"labels":[],"label_agreement":null},{"id":"W2015373259","doi":"10.1007/s40268-014-0057-5","title":"Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperintensity; Medicine; Concomitant; Internal medicine; Cognitive decline; Confounding; Montreal Cognitive Assessment; Stroke (engine); Disease; Retrospective cohort study; Cognition; Pediatrics; Magnetic resonance imaging; Psychiatry; Dementia","score_opus":0.012766708429206216,"score_gpt":0.30807517944199514,"score_spread":0.2953084710127889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015373259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623764,0.0009872452,0.000018158224,0.00030510136,0.000036813588,0.0016030694,0.00008409303,0.000015731397,0.0007121757],"genre_scores_gemma":[0.9988199,0.000027225029,0.000016258182,0.00044524044,0.00005250208,0.0002651351,0.00016602132,0.00003153735,0.00017620128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808663,0.000216874,0.0003153142,0.00044397905,0.0005648283,0.0003723933],"domain_scores_gemma":[0.9990425,0.00024916918,0.00007548252,0.00024458815,0.0001392531,0.00024901598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002482653,0.00022429439,0.0003887527,0.00022130786,0.000031983796,0.000030479432,0.00013382512,0.000038669157,0.0012934192],"category_scores_gemma":[0.000074059884,0.00016700092,0.00006623638,0.0002618064,0.0001624734,0.00012286843,0.00006965293,0.000278431,0.000054501106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005666241,0.0014311208,0.98699504,0.000032005348,0.00020045857,0.000118118754,0.0025082252,5.35279e-7,0.00017061751,0.000007021212,0.000036145946,0.0028344756],"study_design_scores_gemma":[0.009398734,0.00064840785,0.98641497,0.0008140583,0.00024640426,7.2024426e-7,0.0013246444,0.00010553484,0.00070195395,0.00014381517,0.0000050684775,0.00019571268],"about_ca_topic_score_codex":0.00016882847,"about_ca_topic_score_gemma":0.00012907218,"teacher_disagreement_score":0.0037324927,"about_ca_system_score_codex":0.000051548264,"about_ca_system_score_gemma":0.00011776535,"threshold_uncertainty_score":0.99961954},"labels":[],"label_agreement":null},{"id":"W2024058161","doi":"10.2165/11537800-000000000-00000","title":"MicroRNA: Potential Targets for the Development of Novel Drugs?","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"microRNA; Biology; Epigenetics; Regulation of gene expression; Gene regulatory network; Gene expression; Translation (biology); Gene silencing; Computational biology; Gene; Messenger RNA; Cell biology; Cancer research; Genetics","score_opus":0.01959533176365454,"score_gpt":0.30339705085268964,"score_spread":0.2838017190890351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024058161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072098745,0.99318266,0.0042640385,0.000014878246,0.0004735713,0.0011076747,0.00014420928,0.0000046873115,0.00008729805],"genre_scores_gemma":[0.000971625,0.97979766,0.016361475,0.000023655324,0.0004959876,0.00042940522,0.0014747835,0.00008780711,0.0003575997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862224,0.000033441698,0.00061159756,0.0003675266,0.0001301241,0.00023505812],"domain_scores_gemma":[0.9989836,0.00004226068,0.00037881045,0.0004673961,0.00008645589,0.000041438707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004023618,0.00027257434,0.0004937318,0.00007562304,0.00006672037,0.000013996649,0.00045368655,0.00043217195,0.000011156574],"category_scores_gemma":[0.000061181185,0.00020048443,0.00034900318,0.00009032854,0.00008090721,0.000001712347,0.00017612606,0.00017518556,0.000004585642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026862004,0.00016551108,0.0000014398247,0.004202472,0.00021692923,2.535278e-7,0.00017854945,0.000012537095,0.02139665,0.00004424316,0.00088347803,0.97287107],"study_design_scores_gemma":[0.0003560379,0.0000093707795,0.000014748938,0.00067058933,0.00015271414,0.0000035284236,0.000023857954,0.00001644428,0.0055969744,0.0000067571336,0.9929191,0.0002299027],"about_ca_topic_score_codex":0.000002754081,"about_ca_topic_score_gemma":0.000013248185,"teacher_disagreement_score":0.99203557,"about_ca_system_score_codex":0.000035732868,"about_ca_system_score_gemma":0.00053141854,"threshold_uncertainty_score":0.8175518},"labels":[],"label_agreement":null},{"id":"W2051962629","doi":"10.1007/s40268-015-0082-z","title":"mTOR: A Potential Therapeutic Target in Osteoarthritis?","year":2015,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"PI3K/AKT/mTOR pathway; Osteoarthritis; Cartilage; Medicine; Cancer research; Inflammation; Cell biology; Bioinformatics; Internal medicine; Pathology; Signal transduction; Biology; Anatomy","score_opus":0.02481238498216827,"score_gpt":0.32569452924842207,"score_spread":0.3008821442662538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051962629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022801271,0.99674785,0.00004005761,0.000012978891,0.0008387942,0.00051487185,0.00009058489,0.000013238607,0.0015136019],"genre_scores_gemma":[0.0017045819,0.99594635,0.00025460974,0.0001007177,0.00067689363,0.00023771462,0.00049951643,0.000092474846,0.00048715813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978893,0.00025798182,0.00054963166,0.00062844204,0.00024001322,0.0004346646],"domain_scores_gemma":[0.99909705,0.000015620193,0.00018921342,0.00055919035,0.000051862557,0.00008705647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005252381,0.00040016323,0.00090067415,0.00016706796,0.000020474168,0.000031444633,0.00050170126,0.0006584791,0.000057323046],"category_scores_gemma":[0.000037027894,0.00038799926,0.0002729392,0.00023166231,0.000082546896,0.0000034771515,0.00017476671,0.000425028,0.000068133915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031121763,0.000079426274,0.000024068051,0.0013258412,0.00006623113,0.000047065354,0.00008388958,0.000035122805,0.0002051209,0.000022698277,0.0018470038,0.9962324],"study_design_scores_gemma":[0.0006179616,0.00012950921,0.0000021584754,0.0016738332,0.00005286834,0.00002860663,0.000021729704,0.000005047541,0.00009756128,0.00014133677,0.99680424,0.00042517838],"about_ca_topic_score_codex":0.000028550021,"about_ca_topic_score_gemma":0.000036131805,"teacher_disagreement_score":0.99580723,"about_ca_system_score_codex":0.00015431744,"about_ca_system_score_gemma":0.0006169559,"threshold_uncertainty_score":0.9998572},"labels":[],"label_agreement":null},{"id":"W2072492830","doi":"10.2165/00126839-200809030-00001","title":"A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CpG Oligodeoxynucleotide; Toll-like receptor; Immunology; DNA vaccination; Pharmacology; Immune system; Biology; Innate immune system; Immunization; Gene; Genetics","score_opus":0.008426552575936072,"score_gpt":0.2615718066041785,"score_spread":0.25314525402824245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072492830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027783962,0.97068566,1.0345278e-7,0.000023081837,0.00015041842,0.0011477801,0.0000055581395,0.000008012419,0.00019541357],"genre_scores_gemma":[0.024776848,0.97475046,0.0000051061775,0.000055454766,0.0000055395103,0.00023977757,0.000044374137,0.000020035617,0.00010238552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975394,0.0008762292,0.0010768449,0.00024285814,0.000050302013,0.0002143596],"domain_scores_gemma":[0.9988228,0.00025777638,0.0005508386,0.0003160897,0.000042950476,0.000009526575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034191413,0.00027205743,0.0013213049,0.00032058792,0.000041013274,0.0000036358274,0.00023284164,0.00024654466,0.00006934997],"category_scores_gemma":[0.00020109524,0.00018418492,0.0001549302,0.0004800069,0.000097922915,0.000047713154,0.00012000491,0.00037916188,0.000033251003],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008607005,0.00022550144,0.0012557597,0.031131577,0.00012073291,0.000002187088,0.00085026637,4.6921429e-7,0.00021594237,0.000120940465,0.00004329288,0.9659473],"study_design_scores_gemma":[0.0007067381,0.00007042976,0.0024065964,0.07453814,0.000115581875,0.00008061708,0.000057678382,2.5799372e-7,0.0010141382,0.00008384558,0.92067087,0.0002550847],"about_ca_topic_score_codex":0.00011286607,"about_ca_topic_score_gemma":0.000045444634,"teacher_disagreement_score":0.96569216,"about_ca_system_score_codex":0.00014506458,"about_ca_system_score_gemma":0.000554609,"threshold_uncertainty_score":0.7510843},"labels":[],"label_agreement":null},{"id":"W2079921819","doi":"10.2165/00126839-200607020-00006","title":"Effect of a Novel Molybdenum Ascorbate Complex on Ex Vivo Myocardial Performance in Chemical??Diabetes Mellitus","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Allison University","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Streptozotocin; Endocrinology; Cardiac function curve; Insulin; Heart failure; Cardiology","score_opus":0.007668220954864185,"score_gpt":0.22993033327948179,"score_spread":0.2222621123246176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079921819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428698,0.000115498915,0.0000012489791,0.000040167502,0.00004950423,0.00006946085,0.000052558047,0.000030696046,0.056771073],"genre_scores_gemma":[0.9993082,0.000016451722,0.00005667666,0.00003738354,0.00015758481,0.00003049258,0.000086328524,0.000023464714,0.0002834143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986802,0.000016976275,0.0003872744,0.00030179534,0.00026450682,0.00034924908],"domain_scores_gemma":[0.99930584,0.00021210595,0.00011190579,0.00029190953,0.000028126962,0.000050097122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024173145,0.00021058586,0.00036055638,0.00008838555,0.000021175656,0.000013216655,0.0002388289,0.000173209,0.00022927254],"category_scores_gemma":[0.0000488327,0.00021266814,0.00010063834,0.0002019664,0.0000848842,0.000049753857,0.000046261805,0.00025152764,0.000017750397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008758631,0.00020999409,0.028021516,0.0005355692,0.000014789417,0.0000035772428,0.000112287074,0.00078347046,0.96792644,0.00008657172,0.00030035616,0.0019178261],"study_design_scores_gemma":[0.002030897,0.00002502371,0.0023318238,0.00015266462,0.000010079499,0.0000014198383,0.000018565079,0.0027822917,0.9913395,0.000026954556,0.0010745263,0.00020624486],"about_ca_topic_score_codex":0.00011295647,"about_ca_topic_score_gemma":0.000009358732,"teacher_disagreement_score":0.05648766,"about_ca_system_score_codex":0.0001452881,"about_ca_system_score_gemma":0.00003103397,"threshold_uncertainty_score":0.8672355},"labels":[],"label_agreement":null},{"id":"W2083411973","doi":"10.2165/00126839-200607020-00005","title":"Gut Transport of a Molybdenum/Ascorbic Acid Complex","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Chromium effects and bioremediation","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Allison University","funders":"","keywords":"Molybdenum; Ascorbic acid; Small intestine; Incubation; Biochemistry; Chemistry; Biophysics; Biology; Inorganic chemistry; Food science","score_opus":0.00581913416401765,"score_gpt":0.2082372168515531,"score_spread":0.20241808268753547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083411973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911217,0.000016862314,0.000099560675,0.00007585305,0.00004533946,0.00011060703,0.0000065012855,0.000011843751,0.008511702],"genre_scores_gemma":[0.99928445,0.000003314382,0.00048147808,0.00004165921,0.000031361415,0.000005090934,0.000023870904,0.0000048352367,0.00012395016],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993936,0.000015491005,0.00015716233,0.00012820784,0.00018407975,0.000121487494],"domain_scores_gemma":[0.9998142,0.000014812519,0.000043851516,0.00010597108,0.0000018570688,0.000019305813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012896452,0.00006157045,0.00009491632,0.000024443116,0.000016221524,0.0000022771758,0.000089220826,0.00003338347,0.0008672577],"category_scores_gemma":[0.0000030713788,0.000053749573,0.000042196945,0.00016168956,0.00008586767,0.000058954283,0.000018783523,0.000043100295,0.00008098608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019401798,0.00017815351,0.37420237,0.000019512458,0.000002338777,0.0000066647144,0.00062559004,0.0008905272,0.6183103,0.000264524,0.0013724447,0.0041081873],"study_design_scores_gemma":[0.0003667471,0.000023830462,0.97799057,0.00000782554,0.0000042612346,9.3635435e-7,0.00003499084,0.00051559554,0.019555543,0.0003216536,0.0010995312,0.000078539546],"about_ca_topic_score_codex":0.0017757998,"about_ca_topic_score_gemma":0.0007254989,"teacher_disagreement_score":0.6037882,"about_ca_system_score_codex":0.000061065904,"about_ca_system_score_gemma":0.000004027971,"threshold_uncertainty_score":0.94958633},"labels":[],"label_agreement":null},{"id":"W2117988243","doi":"10.2165/11593390-000000000-00000","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Opioid; Anesthesia; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","score_opus":0.0124207090589173,"score_gpt":0.26841392998418573,"score_spread":0.25599322092526844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117988243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684465,0.00047585196,0.0000064987757,0.000042170966,0.0002527583,0.0011444356,0.000009789041,0.000037670237,0.0011862023],"genre_scores_gemma":[0.998722,0.0002548173,0.0006060619,0.000061980165,0.000045532423,0.00014900963,0.000019993246,0.000053290136,0.00008729783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979134,0.000094592404,0.0005000094,0.0005448883,0.0004034341,0.0005436448],"domain_scores_gemma":[0.9989283,0.00012420668,0.0001655014,0.000522072,0.00004928935,0.00021063602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022317929,0.00038483113,0.0007180068,0.0005730577,0.00003765472,0.000012308458,0.00017434581,0.00014943788,0.00015592542],"category_scores_gemma":[0.00007768692,0.0003244825,0.00011364412,0.00047308754,0.000089498055,0.00009912463,0.00007929846,0.00038470948,0.000024093195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027730863,0.009903467,0.6413534,0.0008197724,0.00037914442,0.0021573359,0.28900445,0.00008310922,0.020940524,0.000642423,0.00010578475,0.031837508],"study_design_scores_gemma":[0.0066826427,0.003411312,0.9467455,0.0006546377,0.00007420383,0.0000942401,0.004186672,0.00012688737,0.037336953,0.0003262626,0.0000045112515,0.00035617565],"about_ca_topic_score_codex":0.010695559,"about_ca_topic_score_gemma":0.00022781233,"teacher_disagreement_score":0.3053921,"about_ca_system_score_codex":0.0005058937,"about_ca_system_score_gemma":0.00019724818,"threshold_uncertainty_score":0.9999207},"labels":[],"label_agreement":null},{"id":"W2160030763","doi":"10.1007/s40268-014-0044-x","title":"Bioequivalence Study of Two Formulations of Ibandronic Acid 150-mg Film-Coated Tablets in Healthy Volunteers Under Fasting Conditions: A Randomized, Open-Label, Three-Way, Reference-Replicated Crossover Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Bioequivalence; Crossover study; Confidence interval; Pharmacokinetics; Chromatography; Dosing; Bioavailability; Medicine; Chemistry; Pharmacology; Internal medicine","score_opus":0.06410950267279548,"score_gpt":0.3873579237050685,"score_spread":0.323248421032273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160030763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927258,0.00067873974,0.0002835834,0.00019078444,0.000050789273,0.0049936273,0.00004306844,0.000035586712,0.0009980332],"genre_scores_gemma":[0.9986725,0.00032157952,0.00019671871,0.000060175043,0.000010057048,0.0005891694,0.000064925,0.000029129216,0.00005575875],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99661976,0.00056475727,0.0012390317,0.00048462444,0.0005778315,0.00051401503],"domain_scores_gemma":[0.9978233,0.00072907936,0.00033997436,0.00064535416,0.00033117775,0.00013114478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002313091,0.00023432798,0.0011707754,0.0005049625,0.0001505757,0.00005023278,0.00039743856,0.00007705602,0.00019709328],"category_scores_gemma":[0.0008467753,0.00020141658,0.0000501583,0.000965695,0.000327491,0.00032638467,0.00023786182,0.00041464067,0.000013026868],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2647582,0.042275004,0.5969469,0.00068167323,0.0015379848,0.00004834783,0.041696515,0.0024720812,0.020645738,0.023810139,0.00027171065,0.0048556915],"study_design_scores_gemma":[0.85685,0.008268449,0.0890486,0.0014517632,0.000055408236,0.000012272508,0.010734826,0.02602129,0.0008589883,0.0062275873,0.00003183477,0.00043894319],"about_ca_topic_score_codex":0.012216041,"about_ca_topic_score_gemma":0.009822089,"teacher_disagreement_score":0.5920918,"about_ca_system_score_codex":0.00012619964,"about_ca_system_score_gemma":0.00024719723,"threshold_uncertainty_score":0.9943617},"labels":[],"label_agreement":null},{"id":"W2520135767","doi":"10.1007/s40268-016-0142-z","title":"Safety of Mebendazole Use During Lactation: A Case Series Report","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Mebendazole; Breastfeeding; Medicine; Adverse effect; Lactation; Irritability; Pediatrics; Obstetrics; Pregnancy; Internal medicine; Anxiety; Psychiatry; Biology","score_opus":0.021021296830093232,"score_gpt":0.2973752522973009,"score_spread":0.27635395546720765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520135767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919955,0.000048128015,0.00000912102,0.0046926322,0.00013371074,0.000084083076,0.000007339521,0.000021817543,0.003007658],"genre_scores_gemma":[0.9966796,0.00007802403,0.00074955396,0.00003626917,0.000080567865,0.000005016158,0.0000018002901,0.0000070570186,0.0023621025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931777,0.00001795802,0.00029138496,0.00012932469,0.00013499788,0.00010855881],"domain_scores_gemma":[0.9994503,0.00010799757,0.00014649548,0.00017294408,0.0000775171,0.0000447192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022403052,0.00006173685,0.00014526736,0.00006400491,0.000029246165,0.0000069502535,0.00002788766,0.00003933967,0.0001653339],"category_scores_gemma":[0.00032494366,0.00004054235,0.000031611187,0.00011186335,0.00006500553,0.0005788757,0.000024059447,0.00006182147,0.00000820986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027971438,0.00028661249,0.8783738,0.00048174837,0.00014657406,0.016417671,0.007625449,0.000017804656,0.03552412,0.0023616806,0.0006031343,0.055364277],"study_design_scores_gemma":[0.0024585086,0.00011283422,0.8941946,0.0007401058,0.000063847474,0.06639475,0.0016095183,0.0000142744575,0.019221978,0.00010322338,0.014911168,0.00017518007],"about_ca_topic_score_codex":0.00032632495,"about_ca_topic_score_gemma":0.00005648392,"teacher_disagreement_score":0.055189095,"about_ca_system_score_codex":0.000032939875,"about_ca_system_score_gemma":0.000045785688,"threshold_uncertainty_score":0.18102902},"labels":[],"label_agreement":null},{"id":"W2530554915","doi":"10.1007/s40268-016-0145-9","title":"Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Bioequivalence; Acetaminophen; Medicine; Pharmacokinetics; Caffeine; Pharmacology; Immediate release; Internal medicine","score_opus":0.12560134980769763,"score_gpt":0.43794328977569874,"score_spread":0.3123419399680011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530554915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434215,0.00049830484,0.000029544542,0.0011088416,0.0008628772,0.0022626412,0.00003468676,0.000043364016,0.0008175841],"genre_scores_gemma":[0.9984056,0.00047811546,0.000045878187,0.00038514368,0.00010375355,0.0003693397,0.000006545032,0.000025709414,0.00017996147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961994,0.0015392201,0.00070869655,0.0005745472,0.00041767608,0.0005604352],"domain_scores_gemma":[0.99871814,0.0004702098,0.00024142062,0.00027040238,0.0001227905,0.00017703765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003154419,0.0002884105,0.00050030544,0.0004667997,0.0001199923,0.000010837238,0.00029097998,0.00029180545,0.00041248277],"category_scores_gemma":[0.00020690131,0.00024812177,0.000042782012,0.00059390155,0.00022770558,0.0002596936,0.00014017524,0.000622413,0.000030896957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071958127,0.0039630407,0.3653368,0.00061464467,0.00028021412,0.00005754469,0.039699398,0.0047794404,0.25925145,0.00028912953,0.000395213,0.31813732],"study_design_scores_gemma":[0.09483739,0.0061047156,0.6305457,0.00065388303,0.0008691114,0.000053507978,0.009892108,0.09041473,0.15625097,0.0019136484,0.0062965862,0.0021676898],"about_ca_topic_score_codex":0.0011648034,"about_ca_topic_score_gemma":0.0008557139,"teacher_disagreement_score":0.31596962,"about_ca_system_score_codex":0.0004866483,"about_ca_system_score_gemma":0.00018279803,"threshold_uncertainty_score":0.9999971},"labels":[],"label_agreement":null},{"id":"W2556835195","doi":"10.1007/s40268-016-0153-9","title":"A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI","year":2016,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Sialorrhea; Salivary gland; Medicine; Oral medicine; Dentistry; Dermatology; Internal medicine; Surgery","score_opus":0.0271903309366712,"score_gpt":0.3502844291157385,"score_spread":0.32309409817906726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556835195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011751809,0.9767465,0.00017575345,0.008214578,0.0005900896,0.005877584,0.00009062466,0.00008089785,0.008212227],"genre_scores_gemma":[0.00004506446,0.9805577,0.000057629935,0.0048773466,0.00040085148,0.0020450817,0.00031447608,0.0000867099,0.011615188],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957785,0.0007601684,0.0016170234,0.00078950747,0.00060681376,0.0004479649],"domain_scores_gemma":[0.9946119,0.003211892,0.0005327984,0.00115284,0.00015331626,0.00033721508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022529135,0.00064433395,0.0032947622,0.00073079235,0.00023827147,0.00002911197,0.00030011553,0.00026917606,0.00033310626],"category_scores_gemma":[0.0031695203,0.00031886826,0.00027418096,0.0019039192,0.00021452966,0.00007376388,0.0001056374,0.0007542771,0.00018069593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020737055,0.0002594551,0.00011097637,0.4109089,0.00088760885,0.00003435081,0.0009403416,2.4657362e-7,5.97455e-7,0.00065344747,0.47125426,0.114742436],"study_design_scores_gemma":[0.00085797854,0.000103113474,0.000035703706,0.51756436,0.002610213,0.00012020498,0.0002495248,0.000001830205,6.185322e-8,0.00003280106,0.47818002,0.0002441967],"about_ca_topic_score_codex":0.0003168575,"about_ca_topic_score_gemma":0.0002579388,"teacher_disagreement_score":0.11449824,"about_ca_system_score_codex":0.00037789796,"about_ca_system_score_gemma":0.00037358838,"threshold_uncertainty_score":0.9999263},"labels":[],"label_agreement":null},{"id":"W2579057398","doi":"10.1007/s40268-017-0173-0","title":"A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Meropenem; Dosing; Medicine; Intensive care medicine; Regimen; MEDLINE; Carbapenem; Neutropenia; Internal medicine; Antibiotics; Chemotherapy","score_opus":0.23682066272691937,"score_gpt":0.5424964920427081,"score_spread":0.30567582931578874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579057398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000821135,0.9879986,0.000003905848,0.00009244353,0.00023390303,0.0009802439,0.00002515139,0.0000208793,0.01056277],"genre_scores_gemma":[0.00052967406,0.9981954,0.00025495177,0.00025952447,0.00011183049,0.000007629878,0.00014137919,0.000061969804,0.0004376215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970822,0.00025843745,0.0016490192,0.0003900145,0.00034296967,0.00027739597],"domain_scores_gemma":[0.99691874,0.0005233406,0.0015543865,0.0007236257,0.00016094574,0.00011898763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001769242,0.000384728,0.004725152,0.00012830817,0.000040380164,0.000033138276,0.00036131937,0.00021545563,0.000066232074],"category_scores_gemma":[0.00094127323,0.00023603252,0.00070579926,0.00019873428,0.00021932389,0.00005179719,0.00011496607,0.0008128993,0.00002296693],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016992364,0.0003526719,0.0016468927,0.12676138,0.0007947941,0.00007980738,0.000028714765,3.6907483e-7,3.8147522e-8,0.00016783402,0.0011577739,0.86899275],"study_design_scores_gemma":[0.0011013573,0.00008261817,0.0009765508,0.42947936,0.002451067,0.000009127989,0.000010997969,0.0000053050285,1.4885421e-7,0.000005336301,0.56567377,0.00020436411],"about_ca_topic_score_codex":0.000045865192,"about_ca_topic_score_gemma":0.0000111143345,"teacher_disagreement_score":0.86878836,"about_ca_system_score_codex":0.000048719587,"about_ca_system_score_gemma":0.00089872425,"threshold_uncertainty_score":0.9625127},"labels":[],"label_agreement":null},{"id":"W2603821422","doi":"10.1007/s40268-017-0180-1","title":"Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Canadian Cancer Society Research Institute","keywords":"Cyclin-dependent kinase; Glioma; Glioblastoma; Repurposing; Disease; Medicine; Population; Biology; Bioinformatics; Cancer research; Cancer; Cell cycle; Internal medicine","score_opus":0.08373018955416103,"score_gpt":0.4042266653883339,"score_spread":0.32049647583417284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603821422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00120843,0.9947694,7.8747803e-7,0.00005992435,0.00023953778,0.0028062405,0.00014045546,0.00002184257,0.00075341103],"genre_scores_gemma":[0.00121526,0.9961106,0.0006043549,0.000005699495,0.00046342713,0.0011242263,0.0001793979,0.00006732991,0.00022968484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819976,0.000037300764,0.0008370584,0.00041959796,0.00018672475,0.00031953337],"domain_scores_gemma":[0.99809635,0.00034812783,0.00070078316,0.0006787439,0.00006995606,0.000106038766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018270589,0.00043870384,0.0027485362,0.00037412258,0.00006965231,0.000020638996,0.0001187959,0.00025962558,0.000018842775],"category_scores_gemma":[0.0001491532,0.00029635167,0.0010312423,0.00012412164,0.000054787964,0.000039248127,0.000035460125,0.0000696704,0.00003173265],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030752944,0.0004825912,0.00025131422,0.013411744,0.0002682749,0.00006360699,0.00015801091,1.9449199e-7,5.2196697e-7,0.00004517821,0.000121664605,0.98516613],"study_design_scores_gemma":[0.0026028089,0.0006730176,0.000051286384,0.042007323,0.0015838998,0.000039926133,0.000040074257,0.000009804572,0.00012545887,0.000008647438,0.95265263,0.00020513349],"about_ca_topic_score_codex":0.00007710794,"about_ca_topic_score_gemma":0.000012942152,"teacher_disagreement_score":0.98496103,"about_ca_system_score_codex":0.0005001179,"about_ca_system_score_gemma":0.00020470226,"threshold_uncertainty_score":0.99994886},"labels":[],"label_agreement":null},{"id":"W2620644176","doi":"10.1007/s40268-017-0186-8","title":"Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Marketing authorization; Authorization; Drug; Business; Prior authorization; Medicine; Pharmacology; Computer science; Computer security","score_opus":0.25917852282506304,"score_gpt":0.5329395756676412,"score_spread":0.2737610528425781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620644176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901486,0.0026009767,0.00010412298,0.0024818035,0.00095469475,0.00050656206,0.000046682373,0.000008914082,0.0031476254],"genre_scores_gemma":[0.9976073,0.00087976136,0.00037175702,0.00046267713,0.00023679191,0.000039761067,0.000023643579,0.000008408042,0.0003699117],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986183,0.00046096285,0.00042246084,0.0001800534,0.0000993635,0.00021887034],"domain_scores_gemma":[0.99787027,0.0013231108,0.0004942086,0.00014562818,0.0000340687,0.000132706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002888141,0.000105178406,0.0003407681,0.000035807596,0.00030996744,0.000013849001,0.00024580216,0.000089762456,0.00008616065],"category_scores_gemma":[0.0017013872,0.0000990205,0.000029138917,0.00003612625,0.00012505578,0.00014048685,0.00007315363,0.0003713515,0.0000015402048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016907191,0.0000772135,0.7588764,0.0004727978,0.000045228866,0.0000012363898,0.0011514033,0.000020418307,0.0014297508,0.00019104437,0.03449204,0.20307341],"study_design_scores_gemma":[0.0013258521,0.000020088224,0.088665046,0.00007887987,0.00015315528,7.3524575e-7,0.0003233183,0.0053997985,0.0093074115,0.00011670709,0.89444137,0.00016762123],"about_ca_topic_score_codex":0.01898591,"about_ca_topic_score_gemma":0.026207497,"teacher_disagreement_score":0.85994935,"about_ca_system_score_codex":0.00004014571,"about_ca_system_score_gemma":0.00012691264,"threshold_uncertainty_score":0.99156165},"labels":[],"label_agreement":null},{"id":"W2736936940","doi":"10.1007/s40268-017-0195-7","title":"Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"CYP2C19; CYP2C9; Pharmacogenomics; Genotyping; Phenytoin; Genotype; Medicine; Pharmacogenetics; Pharmacokinetics; Allele; Middle East; Genetics; Pharmacology; Epilepsy; Biology; Geography; Gene; Psychiatry","score_opus":0.48975655035397786,"score_gpt":0.5137854583330572,"score_spread":0.02402890797907936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736936940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19013874,0.8065779,0.0000010199228,0.00007058557,0.00074445107,0.0011126879,0.00023506115,0.0000116656,0.0011078621],"genre_scores_gemma":[0.10991499,0.88928896,0.00004167818,0.00017532673,0.00028312943,0.00008629262,0.000025582058,0.000055132736,0.0001289241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507624,0.001896063,0.001451397,0.00068020425,0.00027339178,0.00062273385],"domain_scores_gemma":[0.9966277,0.001502598,0.0009138827,0.0006442501,0.00004674901,0.00026484224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014498333,0.0006882049,0.0021746256,0.0003636506,0.00014684818,0.000045886074,0.0009229293,0.00062540296,0.000050307823],"category_scores_gemma":[0.00018767951,0.000454885,0.00058295304,0.00028035187,0.0006550312,0.000051343664,0.00028059306,0.001996142,0.000016389868],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001338539,0.00089802954,0.08179744,0.0009864542,0.0004811782,0.00013998071,0.0024721674,0.000024473447,0.000001375139,0.00004210713,0.00056738016,0.91245556],"study_design_scores_gemma":[0.0041677183,0.00033328612,0.10478692,0.0011022897,0.0022182656,0.00009507204,0.000093486975,0.00036919312,0.0000014156586,0.00015222323,0.885859,0.0008211432],"about_ca_topic_score_codex":0.000058459696,"about_ca_topic_score_gemma":0.00003052322,"teacher_disagreement_score":0.91163445,"about_ca_system_score_codex":0.000058002624,"about_ca_system_score_gemma":0.000232072,"threshold_uncertainty_score":0.9997903},"labels":[],"label_agreement":null},{"id":"W2749649169","doi":"10.1007/s40268-017-0201-0","title":"Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"AbbVie","keywords":"Medicine; Placebo; Urology; Internal medicine; Diabetes mellitus; Population; Diabetic nephropathy; Adverse effect; Anesthesia; Endocrinology; Pathology","score_opus":0.031882359487948354,"score_gpt":0.3793242938575151,"score_spread":0.3474419343695667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749649169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852026,0.00007451916,0.000097385506,0.0004812598,0.00032897672,0.010063203,0.0000032187004,0.00002614773,0.0037227066],"genre_scores_gemma":[0.99843746,0.00002161768,0.00030656467,0.000025811523,0.00009492177,0.0010555648,0.0000036511744,0.000018742185,0.000035643017],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971705,0.0008516351,0.00079544645,0.00027698747,0.0006859646,0.00021944965],"domain_scores_gemma":[0.9975371,0.0007770037,0.0007010661,0.00086785614,0.00007141072,0.00004557684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048571303,0.00021734733,0.001415842,0.00024903734,0.000073734904,0.000024387913,0.00034879657,0.000107692125,0.000020750622],"category_scores_gemma":[0.0005099556,0.00013399852,0.00037530364,0.00015372102,0.00031609807,0.00007522182,0.00007716628,0.00037334155,0.0000015865411],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92867994,0.0003411976,0.06505194,0.00015559461,0.00008579188,0.000008447617,0.000085536725,0.00002104948,0.0047646095,0.00022625845,0.000017572198,0.0005620353],"study_design_scores_gemma":[0.91199654,0.0009368582,0.014632459,0.0011158623,0.000258585,0.0000018661549,0.00001251956,0.0008470573,0.07001897,0.000077123084,0.000001859037,0.000100314224],"about_ca_topic_score_codex":0.0001096697,"about_ca_topic_score_gemma":0.000032858894,"teacher_disagreement_score":0.06525436,"about_ca_system_score_codex":0.00017146814,"about_ca_system_score_gemma":0.00012628587,"threshold_uncertainty_score":0.5464301},"labels":[],"label_agreement":null},{"id":"W2751648725","doi":"10.1007/s40268-017-0207-7","title":"Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Benzodiazepine; Adverse effect; Intensive care medicine; Dementia; Psychiatry; Harm; Disease; Pharmacology; Psychology; Internal medicine","score_opus":0.6375684566135268,"score_gpt":0.6246672980506429,"score_spread":0.012901158562883874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751648725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010080823,0.9882733,9.3996654e-8,0.0015190067,0.00021950855,0.0027136565,0.000052222884,0.000023874221,0.0061902157],"genre_scores_gemma":[0.00054126896,0.99690264,0.0001300077,0.0010215752,0.00006237665,0.00013530267,0.0005566883,0.000042382657,0.0006077296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99378926,0.002196207,0.002121869,0.0007565184,0.0006009718,0.0005351687],"domain_scores_gemma":[0.9940457,0.002926477,0.001273582,0.0013279167,0.00016808558,0.0002582785],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010067209,0.00045141784,0.004200117,0.0007283173,0.0000675104,0.0000115519815,0.00040354492,0.00040851653,0.00025739017],"category_scores_gemma":[0.011309187,0.00029390564,0.00036181574,0.0005250415,0.0002769225,0.0001942295,0.00022252361,0.0018285917,0.000050424875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001652039,0.0007217469,0.023705775,0.18737084,0.00027332111,0.00040102898,0.00016509113,1.6682041e-7,2.0561646e-7,0.0004724549,0.0023643177,0.7843599],"study_design_scores_gemma":[0.00095755025,0.00021915551,0.0047555333,0.13352366,0.00057546986,0.000028751436,0.000055274777,0.000016965463,4.4509403e-7,0.00012146577,0.8594828,0.00026288535],"about_ca_topic_score_codex":0.0002296823,"about_ca_topic_score_gemma":0.000017604401,"teacher_disagreement_score":0.85711855,"about_ca_system_score_codex":0.00016064207,"about_ca_system_score_gemma":0.00030775194,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W27770296","doi":"10.1007/s40268-016-0139-7","title":"Types of Support Accessed by Families of Young Children with Disabilities Living in Alberta.","year":2004,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Family and Disability Support Research","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology; Sample (material); Family income; Gerontology; Developmental psychology; Medicine; Economic growth","score_opus":0.01601996718566453,"score_gpt":0.3137259607633713,"score_spread":0.2977059935777068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W27770296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96697336,0.000100825884,0.00000581248,0.000119053504,0.000059501912,0.00028225526,0.00003449508,0.000010414828,0.03241429],"genre_scores_gemma":[0.99891007,0.000014417418,0.000055447705,0.000025867486,0.000011640443,0.00004518607,0.000033008335,0.000016343003,0.00088800956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856544,0.00010067166,0.00043369323,0.00030293828,0.00025721354,0.0003400213],"domain_scores_gemma":[0.99890256,0.000530283,0.00007440414,0.00040681678,0.000040445997,0.00004550782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043159263,0.00013773656,0.00033353985,0.00016558486,0.00001759789,0.000008687701,0.0002988894,0.000105723884,0.0008476716],"category_scores_gemma":[0.00025837065,0.000118200755,0.000048359132,0.00040399504,0.00052117324,0.00014336963,0.00007390001,0.00019165293,0.000026217533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111398505,0.00071342255,0.9645601,0.00007279363,0.000031058316,0.0000010785234,0.031991713,0.00006575316,0.00012732582,0.0016675944,0.00020080945,0.00045693622],"study_design_scores_gemma":[0.0008705408,0.00020212233,0.95764834,0.00009493786,0.000007198075,0.0000035428855,0.038788717,0.0000022567776,0.0015437512,0.0006747063,0.000023573655,0.00014032047],"about_ca_topic_score_codex":0.06234437,"about_ca_topic_score_gemma":0.015560443,"teacher_disagreement_score":0.046783928,"about_ca_system_score_codex":0.000058830516,"about_ca_system_score_gemma":0.00010980751,"threshold_uncertainty_score":0.9438996},"labels":[],"label_agreement":null},{"id":"W2802063352","doi":"10.1007/s40268-018-0232-1","title":"A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"GlaxoSmithKline","keywords":"Nasal administration; Cmax; Pharmacokinetics; Medicine; Pharmacodynamics; Pharmacology; Bioavailability; Nasal spray; Dosing; Area under the curve; Oral administration; Anesthesia","score_opus":0.01161056248182597,"score_gpt":0.32922099346729156,"score_spread":0.3176104309854656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802063352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788076,0.00011695126,0.000037527792,0.00016670664,0.00011220694,0.0015098671,0.000009891949,0.0000070616616,0.00015902682],"genre_scores_gemma":[0.99971294,0.000029998195,0.00008753888,0.000024912875,0.00006947471,0.000037788846,0.0000024058884,0.0000217888,0.000013168253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848,0.00012741638,0.0003991182,0.0002579654,0.0004561292,0.00027937436],"domain_scores_gemma":[0.99929863,0.00006770824,0.00012004069,0.0002980662,0.00014318396,0.00007238489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035912462,0.00015528915,0.00033754925,0.0002704091,0.000020389974,0.000004738818,0.00018269343,0.000035355908,0.00004311987],"category_scores_gemma":[0.00002802638,0.00010290792,0.000030827567,0.00061750755,0.00045869395,0.000045290144,0.00017628135,0.00031771304,6.2895106e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007840861,0.019293629,0.6817237,0.0009095261,0.00055345974,0.0001635539,0.031717334,0.00018957966,0.13936648,0.000059010406,0.0000204616,0.11816237],"study_design_scores_gemma":[0.110070795,0.022134153,0.5541448,0.0005274255,0.00032393218,0.00006633171,0.008673143,0.12081164,0.18285805,0.00003002261,0.00004056036,0.00031913057],"about_ca_topic_score_codex":0.00020912036,"about_ca_topic_score_gemma":0.00048208341,"teacher_disagreement_score":0.12757893,"about_ca_system_score_codex":0.00024014914,"about_ca_system_score_gemma":0.00006382284,"threshold_uncertainty_score":0.41964632},"labels":[],"label_agreement":null},{"id":"W2898934370","doi":"10.1007/s40268-018-0253-9","title":"Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies","year":2018,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Randomized controlled trial; Medicine; Budesonide; Internal medicine; Meta-analysis; Eosinophilic esophagitis; Cochrane Library; Placebo; Confidence interval; Relative risk; Adverse effect; Gastroenterology; Asthma; Pathology; Disease","score_opus":0.06042388775615146,"score_gpt":0.3792141270448372,"score_spread":0.3187902392886857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898934370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014376433,0.9795119,0.0000017191741,0.00019576054,0.00002184415,0.018578015,0.00016915306,0.000008212174,0.00007570643],"genre_scores_gemma":[0.008328246,0.98935914,0.00020655004,0.00008714215,0.0000147338615,0.0017676578,0.00010777382,0.000040725678,0.000088050816],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98902816,0.004318784,0.005164989,0.0006752572,0.00054298283,0.00026984123],"domain_scores_gemma":[0.9846258,0.011047676,0.0028326167,0.0011130816,0.00029754336,0.00008324954],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00803443,0.0008018724,0.046659265,0.0011261201,0.000033845397,0.00001187475,0.00023070705,0.00024172405,0.000033836943],"category_scores_gemma":[0.0026690138,0.00038518512,0.002749715,0.0014088968,0.0019444338,0.000053284835,0.00009590857,0.00021197654,8.754073e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011468973,0.0004475772,0.000007065642,0.709724,0.27138442,0.000026619227,0.0056076176,2.2268696e-7,1.9147949e-7,0.00009567882,0.000011020772,0.0012266318],"study_design_scores_gemma":[0.18644233,0.00017858828,0.000012566352,0.07940019,0.73344517,0.00003899219,0.00016807228,0.00001107029,0.000002199688,0.00004100889,0.000080291065,0.00017954706],"about_ca_topic_score_codex":0.00019261739,"about_ca_topic_score_gemma":0.000052691084,"teacher_disagreement_score":0.6303238,"about_ca_system_score_codex":0.000104872204,"about_ca_system_score_gemma":0.00011023143,"threshold_uncertainty_score":0.99986},"labels":[],"label_agreement":null},{"id":"W2900862674","doi":"10.1007/s40268-018-0255-7","title":"Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Institut de Recherches Servier","keywords":"Shake; Perindopril; Medicine; Post-hoc analysis; Observational study; Internal medicine; Post hoc; Cardiology; Engineering; Blood pressure","score_opus":0.06154146838293655,"score_gpt":0.2998606053313985,"score_spread":0.23831913694846196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900862674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875084,0.00238226,0.0000015143804,0.008832608,0.00003490287,0.0010551008,0.000069227994,0.000009265368,0.000106681655],"genre_scores_gemma":[0.9935129,0.00013764418,0.000115139745,0.0058332435,0.000027942468,0.000118739765,0.0000058192563,0.00001244277,0.00023608287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985948,0.00013374271,0.00036009765,0.00033306962,0.0003686053,0.00020967267],"domain_scores_gemma":[0.9979702,0.0005212128,0.00014233199,0.0003354098,0.0009868698,0.00004394398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036053752,0.00020632375,0.00071387447,0.00011830995,0.00046380117,0.000018688037,0.00013177675,0.0000516198,0.00001025916],"category_scores_gemma":[0.00038688714,0.00009011494,0.000055128166,0.0007377278,0.00078837265,0.00006406839,0.00029177952,0.00019671486,6.5310763e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023195657,0.00022789366,0.9139791,0.000072757284,0.003386469,0.000012998617,0.07570365,0.000065378605,0.001022784,0.00024070729,0.0017702011,0.0011984945],"study_design_scores_gemma":[0.0022977202,0.00094627263,0.9817303,0.00035469048,0.0014741911,0.000008106439,0.0100716,0.0013711812,0.000791526,0.000054676482,0.0007421831,0.00015759387],"about_ca_topic_score_codex":0.0004403167,"about_ca_topic_score_gemma":0.003094075,"teacher_disagreement_score":0.067751154,"about_ca_system_score_codex":0.00001752077,"about_ca_system_score_gemma":0.000060604343,"threshold_uncertainty_score":0.36747807},"labels":[],"label_agreement":null},{"id":"W2919757880","doi":"10.1007/s40268-019-0263-2","title":"Ulcerative Colitis: Shifting Sands","year":2019,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Medicine; Ulcerative colitis; Disease; Inflammatory bowel disease; Quality of life (healthcare); Proctitis; Internal medicine; Colitis; Intensive care medicine; Gastroenterology","score_opus":0.021497418436796062,"score_gpt":0.31606787759129235,"score_spread":0.2945704591544963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919757880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082301965,0.9848055,0.0000061802875,0.0000028172979,0.00033394547,0.00067221647,0.000093101946,0.000013354361,0.013249813],"genre_scores_gemma":[0.0004122568,0.9963924,0.000068450536,0.00007709385,0.00040315013,0.00016526387,0.00065768434,0.00006873462,0.0017549229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841636,0.000232502,0.0004091698,0.0005060247,0.0001230643,0.00031285343],"domain_scores_gemma":[0.99915683,0.000026737867,0.00018796015,0.0005154576,0.00003846521,0.000074529955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002761141,0.00032654172,0.0006223063,0.000087944805,0.000035304492,0.000032134027,0.00030247006,0.00040756896,0.000052943506],"category_scores_gemma":[0.000071379975,0.00030958722,0.00030176615,0.00009662959,0.000050191033,0.0000025015447,0.00018009859,0.00024081528,0.00023119285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012358508,0.00010672713,0.0002510784,0.025237933,0.00034315785,0.00024279572,0.00044398324,0.000011958638,0.0000050796075,0.0011900613,0.0062017133,0.96584195],"study_design_scores_gemma":[0.000250512,0.000018775163,0.00029270354,0.0026818514,0.000105823994,0.0000065273857,0.000040662635,0.0000033535835,0.000005304088,0.000015494186,0.9961987,0.00038028654],"about_ca_topic_score_codex":0.000007988785,"about_ca_topic_score_gemma":0.000030163497,"teacher_disagreement_score":0.98999697,"about_ca_system_score_codex":0.00006380784,"about_ca_system_score_gemma":0.00044627473,"threshold_uncertainty_score":0.9999356},"labels":[],"label_agreement":null},{"id":"W3020645024","doi":"10.1007/s40268-020-00307-2","title":"Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval; Institut National de Santé Publique du Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Institut National de Santé Publique du Québec","keywords":"Angiotensin Receptor Blockers; Pharmacology; Brand names; Business; Chemistry; Medicine; Internal medicine; Renin–angiotensin system; Advertising","score_opus":0.10373590454889006,"score_gpt":0.28739270910938797,"score_spread":0.1836568045604979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020645024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75284266,0.000817324,0.00026135036,0.24408124,0.00042691297,0.00021483559,0.00048058378,0.000041756262,0.0008333191],"genre_scores_gemma":[0.90756863,0.00018611182,0.0020114582,0.089675136,0.0002993435,0.000033784443,0.000035849418,0.000044189717,0.00014550271],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979302,0.00003062299,0.0007789919,0.0005995353,0.000040484494,0.0006201536],"domain_scores_gemma":[0.9988492,0.00007031884,0.00018135979,0.00029462046,0.000009403755,0.00059510383],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00035541708,0.00023826907,0.00067782943,0.00022333398,0.000095507654,0.00011578094,0.00031505286,0.00010233007,0.0010147132],"category_scores_gemma":[0.00011451491,0.0002671138,0.00017091612,0.00031768516,0.000025958787,0.00017388513,0.00024002079,0.00027835296,0.0013177588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017781448,0.00041001107,0.84484595,0.000057831272,0.00030379352,0.000011378842,0.035881594,0.00020831278,0.00015726984,0.023571331,0.0714888,0.022885917],"study_design_scores_gemma":[0.001504822,0.00007905866,0.14030385,0.000015880818,0.0000038498797,4.6223903e-7,0.00010398717,0.0055378242,0.00006832211,0.003867316,0.84790003,0.0006145685],"about_ca_topic_score_codex":0.00068431644,"about_ca_topic_score_gemma":0.00007909807,"teacher_disagreement_score":0.77641124,"about_ca_system_score_codex":0.00024059789,"about_ca_system_score_gemma":0.00004593614,"threshold_uncertainty_score":0.9999781},"labels":[],"label_agreement":null},{"id":"W3085493311","doi":"10.1007/s40268-020-00322-3","title":"Nimodipine Pharmacokinetic Variability in Various Patient Populations","year":2020,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nimodipine; Medicine; Pharmacokinetics; Subarachnoid hemorrhage; Dosing; Anesthesia; MEDLINE; Clinical significance; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.04794077184678272,"score_gpt":0.3501292232052786,"score_spread":0.3021884513584959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085493311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002506422,0.9873139,0.00009416478,0.0008333779,0.00033040246,0.0028050358,0.00009473655,0.000092890325,0.00818482],"genre_scores_gemma":[0.0074821245,0.9891906,0.001222129,0.00020359027,0.00019620724,0.00076006784,0.00075566117,0.00005166853,0.00013796757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980092,0.00022544271,0.00081041455,0.0004961647,0.00019922291,0.00025952098],"domain_scores_gemma":[0.99912775,0.0001481157,0.00015950641,0.00040694964,0.000041769854,0.00011590453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014994683,0.0003332825,0.0012282609,0.0002468926,0.000039642993,0.000012923455,0.00014418236,0.00017261396,0.00027193423],"category_scores_gemma":[0.00010581299,0.00028000228,0.00025544854,0.0008327691,0.000037239788,0.000031677202,0.00006838869,0.0005701881,0.00020183942],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001658969,0.0006976315,0.0002758003,0.0024397122,0.000040036986,0.00011169453,0.00033614278,0.0000043560476,5.332423e-7,0.0017208799,0.0001962911,0.99416035],"study_design_scores_gemma":[0.00075912103,0.00011513251,0.00091460376,0.0027041764,0.0008100125,0.00009264246,0.000013519156,0.0004385881,5.2265347e-7,0.001162776,0.99268794,0.00030097069],"about_ca_topic_score_codex":0.00015985234,"about_ca_topic_score_gemma":0.00002257111,"teacher_disagreement_score":0.99385935,"about_ca_system_score_codex":0.00040374187,"about_ca_system_score_gemma":0.00023461512,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W3092259600","doi":"10.1007/s40268-020-00323-2","title":"Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Alberta","funders":"National Research Foundation of Korea","keywords":"Pharmacokinetics; Phenytoin; Pharmacology; Medicine; Chemistry; Epilepsy","score_opus":0.07519172777881467,"score_gpt":0.3256941495750178,"score_spread":0.25050242179620313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092259600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945946,0.00007119053,0.0032146443,0.0004962612,0.00010052889,0.0013624054,0.000017385675,0.000013102217,0.00012990557],"genre_scores_gemma":[0.99766105,0.000041943564,0.0016909069,0.00046222613,0.00007627452,0.00003711419,0.0000072813104,0.00002105575,0.0000021354745],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984416,0.0001204194,0.0005663343,0.00024841187,0.00032124543,0.00030201234],"domain_scores_gemma":[0.9992697,0.00018434337,0.00021434361,0.00011754111,0.0001311703,0.000082898354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706046,0.00019609313,0.00062828546,0.00010608203,0.000057583948,0.000006523239,0.00015364889,0.00007025582,0.0000035025355],"category_scores_gemma":[0.00022870462,0.00014230331,0.00009195205,0.00042684306,0.000089985515,0.000090316826,0.0001693045,0.00041502118,0.0000011619193],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011369936,0.0013480107,0.044199973,0.0024709434,0.00022947826,0.00004155543,0.010597507,0.15866059,0.7792339,0.00021268064,0.000050850264,0.0018175566],"study_design_scores_gemma":[0.0033812253,0.00020309172,0.0020649852,0.00070452143,0.000077424345,5.329673e-7,0.0003575631,0.91126704,0.08177931,0.000034024277,0.000006842168,0.00012342731],"about_ca_topic_score_codex":0.0000955128,"about_ca_topic_score_gemma":0.0000032138482,"teacher_disagreement_score":0.75260645,"about_ca_system_score_codex":0.00006746554,"about_ca_system_score_gemma":0.000038102895,"threshold_uncertainty_score":0.5802961},"labels":[],"label_agreement":null},{"id":"W3156032412","doi":"10.1007/s40268-021-00345-4","title":"Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperammonemia; Urea cycle; Hepatic encephalopathy; Lactulose; Cirrhosis; Internal medicine; Ornithine; Chemistry; Phenylbutyrate; Medicine; Endocrinology; Biochemistry; Pharmacology; Arginine; Amino acid","score_opus":0.03239207941204482,"score_gpt":0.3379310956392957,"score_spread":0.3055390162272509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156032412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012175546,0.98610866,0.000016672786,0.000024308609,0.000065818844,0.0014605091,0.00010557552,0.000004406687,0.00003851227],"genre_scores_gemma":[0.004466249,0.9942967,0.000177291,0.000007449669,0.00003420043,0.00043042962,0.0004707783,0.000016309441,0.000100542915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999079,0.000115116185,0.00036095493,0.00021343563,0.00011717489,0.000114357055],"domain_scores_gemma":[0.99941504,0.00024634463,0.00012244523,0.00016158988,0.000020645311,0.000033925822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016212245,0.00015982286,0.00085353805,0.00011900113,0.000017461862,0.000006635568,0.000040412357,0.00008550073,0.000008212905],"category_scores_gemma":[0.00000854366,0.00010447473,0.00023226782,0.00021214107,0.00003103843,0.00003086652,0.0000053922818,0.000059081365,9.330071e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032859818,0.00023993956,0.00048732356,0.0066915886,0.00036495435,0.000019717507,0.0012552266,2.5517997e-7,0.0000022756412,0.000052046325,0.000007697406,0.9908461],"study_design_scores_gemma":[0.012133905,0.0010088685,0.0068144556,0.08227878,0.05397087,0.00014909988,0.0017041354,0.00023672465,0.0003725023,0.00024523668,0.8402282,0.0008572268],"about_ca_topic_score_codex":0.00019820005,"about_ca_topic_score_gemma":0.00005580202,"teacher_disagreement_score":0.98998886,"about_ca_system_score_codex":0.00007145192,"about_ca_system_score_gemma":0.00016132231,"threshold_uncertainty_score":0.42603558},"labels":[],"label_agreement":null},{"id":"W3173963108","doi":"10.1007/s40268-021-00351-6","title":"Potential for the Repurposing of Adamantane Antivirals for COVID-19","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Amantadine; Memantine; Coronavirus; Rimantadine; Virology; Drug repositioning; Pharmacology; Viral replication; Biology; Virus; Receptor; Medicine; NMDA receptor; Influenza A virus; Drug; Biochemistry; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.11603596838926164,"score_gpt":0.4612790641218202,"score_spread":0.3452430957325585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173963108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007531511,0.9919876,0.0022800558,0.00031169268,0.00036119713,0.004480129,0.00019131145,0.00002475041,0.00028797574],"genre_scores_gemma":[0.000089206136,0.9897472,0.0007406278,0.00719046,0.0006047582,0.001162989,0.000118801305,0.00009681857,0.00024910542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997558,0.00016045425,0.00083416724,0.00054108497,0.0004499811,0.00045631453],"domain_scores_gemma":[0.99626714,0.002431012,0.00032209238,0.000736373,0.00019708501,0.000046295838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001654644,0.00030936845,0.0018756251,0.00030444874,0.00011252952,0.000038563376,0.00039779747,0.00032239602,0.000011918386],"category_scores_gemma":[0.0020118863,0.00020463033,0.0010250922,0.0005356091,0.00015647693,0.000038204802,0.00014747652,0.00040561127,0.000004799051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021286555,0.00017516542,0.000029355226,0.06413417,0.0004210325,0.000103354,0.00028922336,7.0796506e-7,0.0001006299,0.0006195322,0.0039806957,0.92993325],"study_design_scores_gemma":[0.0012543794,0.00012817729,0.0000012768128,0.007538907,0.0009412927,0.000090648915,0.00023001386,0.00013085137,0.00032602248,0.00011217538,0.9890573,0.00018895796],"about_ca_topic_score_codex":0.00011573681,"about_ca_topic_score_gemma":0.000016150578,"teacher_disagreement_score":0.9850766,"about_ca_system_score_codex":0.00026147027,"about_ca_system_score_gemma":0.0023791206,"threshold_uncertainty_score":0.83445823},"labels":[],"label_agreement":null},{"id":"W3200529384","doi":"10.1007/s40268-021-00361-4","title":"The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process","year":2021,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Toronto; University Health Network; University of British Columbia; Alberta Children's Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"Killam Trusts","keywords":"Enzyme replacement therapy; Fabry disease; Medicine; Adverse effect; Internal medicine; Disease","score_opus":0.010119529080312509,"score_gpt":0.31440482041907347,"score_spread":0.304285291338761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200529384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776894,0.00047142067,0.0000033942272,0.0006836796,0.000028732682,0.00077923405,0.00004935147,0.0000031728264,0.00021208587],"genre_scores_gemma":[0.999544,0.00007762979,0.000020861766,0.000088482055,0.0000067072942,0.000068874826,0.00014327289,0.00001397743,0.000036142745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986369,0.0000830656,0.00031841514,0.00018955205,0.000479506,0.0002925619],"domain_scores_gemma":[0.999264,0.00007162942,0.00007784001,0.00025375097,0.0001721946,0.00016055375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032281538,0.0000907139,0.00018176314,0.00014011828,0.000042247288,0.000008347096,0.00008853473,0.00002708702,0.00007972792],"category_scores_gemma":[0.00015289086,0.00006286757,0.000046280496,0.0004992187,0.0000431109,0.00006573132,0.000020390307,0.000103749335,6.9819635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009816238,0.00021866606,0.9833261,0.000083392864,0.000046714096,0.000037601043,0.0031859162,0.0000070099118,0.00016892389,0.000023888584,0.000029132656,0.011891062],"study_design_scores_gemma":[0.0065792976,0.00020426072,0.9807189,0.00020451174,0.000014025505,2.755819e-7,0.00665084,0.000056848843,0.0050564073,0.00003270349,0.0003988072,0.000083092615],"about_ca_topic_score_codex":0.0684661,"about_ca_topic_score_gemma":0.16416916,"teacher_disagreement_score":0.095703065,"about_ca_system_score_codex":0.00029845408,"about_ca_system_score_gemma":0.001307159,"threshold_uncertainty_score":0.93773705},"labels":[],"label_agreement":null},{"id":"W4211044495","doi":"10.1007/bf03259788","title":"Telaprevir","year":2010,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Telaprevir; Virology","score_opus":0.017478495273752663,"score_gpt":0.351250165184447,"score_spread":0.33377166991069435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211044495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8142495,0.000030503816,0.0000049098603,0.00092229445,0.00013057947,0.00014515079,0.000001551012,0.000026827387,0.18448867],"genre_scores_gemma":[0.9955622,0.000037054622,0.001092568,0.0002907279,0.00012852902,0.000019190438,0.000004200745,0.000011800205,0.0028537363],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993627,0.000017871378,0.000109125176,0.00011924153,0.00020647627,0.00018455998],"domain_scores_gemma":[0.99955857,0.00005029915,0.000009643526,0.00025883107,0.000030097377,0.00009258892],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002720689,0.00004789317,0.00010742004,0.00010422379,0.0000149242405,0.0000076941415,0.00007474103,0.000065382366,0.0012307594],"category_scores_gemma":[0.00031246516,0.000041480933,0.000026334103,0.0001688224,0.00005286967,0.00003549814,0.000036310383,0.00047188785,0.0009305918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004015067,0.00015968215,0.7016558,0.00006507477,0.000010540026,0.00012685025,0.00085338065,4.218618e-7,0.029434277,0.0022779156,0.007998573,0.25737733],"study_design_scores_gemma":[0.0015801032,0.00008326781,0.3372941,0.00007212999,0.000007362173,0.000018971303,0.00008886551,0.00067251665,0.011779326,0.0005458437,0.64770687,0.0001506255],"about_ca_topic_score_codex":0.0001422903,"about_ca_topic_score_gemma":0.00014242303,"teacher_disagreement_score":0.6397083,"about_ca_system_score_codex":0.00002169941,"about_ca_system_score_gemma":0.000070862225,"threshold_uncertainty_score":0.9998473},"labels":[],"label_agreement":null},{"id":"W4211130856","doi":"10.2165/11586020-000000000-00000","title":"Telaprevir","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telaprevir; Ribavirin; Medicine; Pegylated interferon; Pharmacology; Protease inhibitor (pharmacology); Hepatitis C virus; Clinical trial; Virology; Combination therapy; Internal medicine; Virus; Viral load","score_opus":0.0885571778742468,"score_gpt":0.45540974985999433,"score_spread":0.3668525719857475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211130856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000872877,0.90161175,0.000001022363,0.000047342546,0.00023064237,0.0009964778,0.00002038853,0.000039589595,0.09704408],"genre_scores_gemma":[0.0000037677366,0.9932773,0.0003676144,0.00006145299,0.00035740485,0.00021161445,0.00009988011,0.00007806223,0.005542873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998169,0.00014038131,0.00051450805,0.00036709924,0.00042489517,0.00038408654],"domain_scores_gemma":[0.9987417,0.00021950793,0.00008753807,0.0007293806,0.000043763383,0.00017809644],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005692766,0.00026264178,0.0015887009,0.00045154284,0.00002105629,0.000019215506,0.00026946753,0.0005868898,0.0009163752],"category_scores_gemma":[0.00050235516,0.00020121789,0.00032226645,0.0004965854,0.00008600423,0.000032313652,0.000128364,0.0021698044,0.0031913617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016640982,0.00004295652,0.00007651531,0.011794967,0.000020254662,0.000106400104,0.000039017898,2.985719e-9,1.3809803e-7,0.000075963515,0.0018041091,0.986038],"study_design_scores_gemma":[0.00018818153,0.00002435347,0.000013324771,0.014599135,0.00011058694,0.000028035818,0.0000030045874,0.0000023394844,5.603638e-7,0.00001470771,0.9848559,0.00015988045],"about_ca_topic_score_codex":0.000064666594,"about_ca_topic_score_gemma":0.000030650936,"teacher_disagreement_score":0.9858781,"about_ca_system_score_codex":0.00018039954,"about_ca_system_score_gemma":0.00069374836,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W4232278611","doi":"10.1007/bf03259727","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Anesthesia; Opioid; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","score_opus":0.0124207090589173,"score_gpt":0.26841392998418573,"score_spread":0.25599322092526844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232278611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684465,0.00047585196,0.0000064987757,0.000042170966,0.0002527583,0.0011444356,0.000009789041,0.000037670237,0.0011862023],"genre_scores_gemma":[0.998722,0.0002548173,0.0006060619,0.000061980165,0.000045532423,0.00014900963,0.000019993246,0.000053290136,0.00008729783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979134,0.000094592404,0.0005000094,0.0005448883,0.0004034341,0.0005436448],"domain_scores_gemma":[0.9989283,0.00012420668,0.0001655014,0.000522072,0.00004928935,0.00021063602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022317929,0.00038483113,0.0007180068,0.0005730577,0.00003765472,0.000012308458,0.00017434581,0.00014943788,0.00015592542],"category_scores_gemma":[0.00007768692,0.0003244825,0.00011364412,0.00047308754,0.000089498055,0.00009912463,0.00007929846,0.00038470948,0.000024093195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027730863,0.009903467,0.6413534,0.0008197724,0.00037914442,0.0021573359,0.28900445,0.00008310922,0.020940524,0.000642423,0.00010578475,0.031837508],"study_design_scores_gemma":[0.0066826427,0.003411312,0.9467455,0.0006546377,0.00007420383,0.0000942401,0.004186672,0.00012688737,0.037336953,0.0003262626,0.0000045112515,0.00035617565],"about_ca_topic_score_codex":0.010695559,"about_ca_topic_score_gemma":0.00022781233,"teacher_disagreement_score":0.3053921,"about_ca_system_score_codex":0.0005058937,"about_ca_system_score_gemma":0.00019724818,"threshold_uncertainty_score":0.9999207},"labels":[],"label_agreement":null},{"id":"W4249646940","doi":"10.1007/bf03262369","title":"Food Effects on the Pharmacokinetics of Doxylamine Hydrogen Succinate 25 mg Film-Coated Tablets","year":2012,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Bioavailability; Antihistamine; Crossover study; Medicine; Chemistry; Placebo","score_opus":0.013966316615822266,"score_gpt":0.2747078549690658,"score_spread":0.26074153835324354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249646940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906282,0.0008166847,0.0000019452912,0.00045850573,0.00020978379,0.000399228,0.000014400171,0.000036706893,0.007434582],"genre_scores_gemma":[0.9985839,0.00005197158,0.0000436912,0.00045243997,0.00011068929,0.000031878917,0.000025998763,0.000024776846,0.00067461556],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898636,0.000082862534,0.00019687171,0.00013991958,0.00023778401,0.00035619884],"domain_scores_gemma":[0.9991917,0.0003167262,0.00007881895,0.00028893212,0.000028155635,0.000095665935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025594074,0.00016380502,0.00026461037,0.000094017174,0.00003479921,0.0000039383117,0.00009738095,0.00006686913,0.0000773096],"category_scores_gemma":[0.00012621867,0.000103984916,0.000062618565,0.00026400518,0.000034167173,0.000039508664,0.000038279108,0.00018187726,0.00006755468],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004873308,0.00830297,0.6914225,0.0017494325,0.0024303386,0.00024244808,0.019283092,0.00030139397,0.20981045,0.004246226,0.018451609,0.03888622],"study_design_scores_gemma":[0.00524741,0.0012504092,0.06899366,0.00044653518,0.00020110217,0.000012528117,0.00010007019,0.0006773248,0.91971225,0.0000580702,0.003140401,0.00016027044],"about_ca_topic_score_codex":0.000046876627,"about_ca_topic_score_gemma":0.0000017984905,"teacher_disagreement_score":0.70990175,"about_ca_system_score_codex":0.00006771216,"about_ca_system_score_gemma":0.000021123064,"threshold_uncertainty_score":0.42403817},"labels":[],"label_agreement":null},{"id":"W4251062930","doi":"10.1007/bf03259789","title":"Boceprevir","year":2010,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boceprevir; Medicine; Pharmacology; Virology; Ribavirin; Hepatitis C virus","score_opus":0.010330449689600741,"score_gpt":0.29738400725835723,"score_spread":0.2870535575687565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251062930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67645544,0.000011547331,0.0000046159344,0.0009208506,0.00043527305,0.00010934842,0.0000012316101,0.00005225538,0.3220094],"genre_scores_gemma":[0.99542713,0.000011640394,0.00097652094,0.00029739994,0.00019234007,0.000012927377,0.0000063708926,0.000013436897,0.0030622245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994788,0.000007637337,0.00011474899,0.00013643016,0.00011392762,0.00014842156],"domain_scores_gemma":[0.9995522,0.000041401072,0.000021688176,0.00028003505,0.000022849768,0.000081847385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012090599,0.00006482617,0.00011781696,0.00010234642,0.000020587146,0.0000054963944,0.00005008609,0.000071387636,0.00009802407],"category_scores_gemma":[0.00012470098,0.0000589307,0.000043591433,0.00016947846,0.00003529581,0.000059783044,0.000020425723,0.00043378663,0.0006116697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018893095,0.0009662602,0.06339888,0.00012309312,0.00006529592,0.00017277985,0.0030077973,0.000008869902,0.36616457,0.021037877,0.0031356167,0.5419001],"study_design_scores_gemma":[0.0014985865,0.000010645251,0.30636048,0.00007742125,0.00003772134,0.00014058796,0.0006514619,0.00017994113,0.011254033,0.0006890891,0.6789144,0.00018559635],"about_ca_topic_score_codex":0.000050274546,"about_ca_topic_score_gemma":0.00003241594,"teacher_disagreement_score":0.6757788,"about_ca_system_score_codex":0.00003212569,"about_ca_system_score_gemma":0.000059103677,"threshold_uncertainty_score":0.786198},"labels":[],"label_agreement":null},{"id":"W4283169331","doi":"10.1007/s40268-022-00391-6","title":"Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Adverse effect; Edaravone; Amyotrophic lateral sclerosis; Postmarketing surveillance; Clinical trial; Disease; Intensive care medicine; Internal medicine","score_opus":0.03374131150750272,"score_gpt":0.31307372465809863,"score_spread":0.2793324131505959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283169331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864593,0.00031619272,0.000040869956,0.009442679,0.00011913333,0.0005966433,0.0022771016,0.000010232436,0.0007378614],"genre_scores_gemma":[0.99721456,0.000053358366,0.00023477801,0.00091967214,0.00010477481,0.00009651908,0.0004096297,0.000014977114,0.00095171673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983063,0.00020742234,0.00028429326,0.0003062452,0.0006683028,0.00022747087],"domain_scores_gemma":[0.9978632,0.0003701098,0.000072535884,0.0016072954,0.00004183326,0.00004504184],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009292496,0.000086631124,0.00029313305,0.000081174796,0.000120019795,0.000010767511,0.00089483813,0.000039945655,0.0018338071],"category_scores_gemma":[0.0001997368,0.00004720296,0.0001463403,0.00096223416,0.00013453867,0.000039213297,0.0010612261,0.00037622737,0.000007933384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029974787,0.00047377415,0.9456369,0.00004278885,0.002610825,0.000010741456,0.0050164117,0.0011045472,0.002074515,0.00040298724,0.034716927,0.0049120598],"study_design_scores_gemma":[0.00091075373,0.00004317677,0.9392733,0.000019692534,0.00047147874,3.8559565e-7,0.00036738292,0.0074411742,0.000035188616,0.000102405145,0.05127342,0.000061663835],"about_ca_topic_score_codex":0.0018632853,"about_ca_topic_score_gemma":0.0003430312,"teacher_disagreement_score":0.01655649,"about_ca_system_score_codex":0.00012568182,"about_ca_system_score_gemma":0.00011257164,"threshold_uncertainty_score":0.99907863},"labels":[],"label_agreement":null},{"id":"W4289299681","doi":"10.1007/s40268-018-0252-x","title":"Acknowledgement to Referees","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Consejo Nacional de Investigaciones Científicas y Técnicas; Semmelweis Egyetem; Feinberg School of Medicine; Nirma University; Monash University; Universität Heidelberg; Universität Basel; University of British Columbia; Cleveland Clinic; Northwestern University","keywords":"Acknowledgement; Medicine; Psychology; Computer science","score_opus":0.011999333055938859,"score_gpt":0.30187290754508883,"score_spread":0.28987357448914997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289299681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90916914,0.00012590688,0.0001502136,0.014885265,0.00043228568,0.00015706017,4.8147433e-7,0.00006260047,0.075017035],"genre_scores_gemma":[0.9929304,0.0000327912,0.0018123843,0.0014710006,0.00013377072,0.00000459841,9.876929e-7,0.000005134281,0.0036089136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996505,0.0000061622386,0.000080372534,0.00010507882,0.00004505001,0.00011283176],"domain_scores_gemma":[0.9997509,0.0000058780997,0.000008218731,0.00016522508,0.000033990378,0.000035792553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007885078,0.00004163207,0.00008074735,0.00010269427,0.000020785943,0.0000013098291,0.00005234028,0.0006476129,0.00039710585],"category_scores_gemma":[0.000035836976,0.00003322162,0.000014443651,0.00018101835,0.000058390855,0.000008377507,0.000042266576,0.00045924252,0.0010319591],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017782772,0.002009063,0.09742136,0.00027175125,0.0005110388,0.00022040072,0.022568587,0.000014055153,0.07434675,0.11671429,0.45271575,0.23142867],"study_design_scores_gemma":[0.0021305692,0.0009495706,0.04540941,0.00038995803,0.00005864914,0.000032296884,0.0010215131,0.00046673178,0.11958412,0.0014422874,0.8282514,0.00026346082],"about_ca_topic_score_codex":0.00000923935,"about_ca_topic_score_gemma":0.00002108264,"teacher_disagreement_score":0.37553567,"about_ca_system_score_codex":0.00002651837,"about_ca_system_score_gemma":0.000017069968,"threshold_uncertainty_score":0.99974585},"labels":[],"label_agreement":null},{"id":"W4312064980","doi":"10.1007/s40268-022-00410-6","title":"A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic Solution","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"Ipsen","keywords":"Tolerability; Medicine; Pharmacokinetics; Adverse effect; Placebo; Internal medicine; Anesthesia","score_opus":0.03184393169426662,"score_gpt":0.3427165005340247,"score_spread":0.31087256883975806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312064980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611247,0.00019883034,0.0001261705,0.001199104,0.00011413655,0.0018302341,0.00001663006,0.000011622605,0.00039080295],"genre_scores_gemma":[0.9994409,0.000019047038,0.000083922634,0.00023835784,0.000023935292,0.00009791046,0.0000072853027,0.0000099354775,0.00007868401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873626,0.00031061235,0.00031504413,0.00019528152,0.00029601523,0.00014678953],"domain_scores_gemma":[0.9994049,0.00014529216,0.00006160062,0.00028795088,0.000044470118,0.000055803845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012085473,0.00009313943,0.0002994632,0.0000641146,0.000090803114,0.0000059893764,0.00009854277,0.000014083864,0.00015297002],"category_scores_gemma":[0.000076124896,0.00007135413,0.00005319188,0.00025548955,0.000029404104,0.000022883916,0.00015122668,0.00021687063,0.0000016069476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059329294,0.017976604,0.6654193,0.00030564348,0.00053521176,0.00026607802,0.05292473,0.0023408842,0.15124314,0.00014632184,0.00023535543,0.04927749],"study_design_scores_gemma":[0.32490924,0.008241562,0.5709973,0.00013426338,0.000995949,0.00007558747,0.05041346,0.01662884,0.020985074,0.00028726764,0.0056016403,0.0007298131],"about_ca_topic_score_codex":0.00014051348,"about_ca_topic_score_gemma":0.000009305607,"teacher_disagreement_score":0.26557994,"about_ca_system_score_codex":0.0000704106,"about_ca_system_score_gemma":0.000058953432,"threshold_uncertainty_score":0.2909737},"labels":[],"label_agreement":null},{"id":"W4319332896","doi":"10.1007/s40268-023-00413-x","title":"Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Domperidone; Medicine; Gastroparesis; Metoclopramide; Meta-analysis; Internal medicine; Adverse effect; Odds ratio; Placebo; Extrapyramidal symptoms; Confidence interval; Antipsychotic; Gastric emptying; Schizophrenia (object-oriented programming); Dopamine; Psychiatry; Pathology","score_opus":0.058121926999395716,"score_gpt":0.3338852237016718,"score_spread":0.27576329670227606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319332896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009041199,0.99585116,0.000008569197,0.00004235623,0.0000050427657,0.0030005928,0.00013992927,0.000021720289,0.000026513144],"genre_scores_gemma":[0.0013790267,0.9975042,0.00031714703,0.000041683015,0.0000021174117,0.00044071153,0.00010642503,0.000035893074,0.00017281123],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963735,0.0010311119,0.0014601944,0.00049068226,0.00037933965,0.0002652124],"domain_scores_gemma":[0.99743986,0.0007998424,0.0010746126,0.0004816544,0.00009159024,0.00011243969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002193716,0.00042983136,0.009717883,0.0006827963,0.000020340938,0.0000034044078,0.00012041976,0.0001166044,0.000026857155],"category_scores_gemma":[0.0029213254,0.000270703,0.0008800334,0.002027303,0.00010062542,0.000046565594,0.00008194776,0.00045033218,0.000004825845],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017936758,0.00012513988,0.0038877921,0.94041693,0.05526032,0.000043764558,0.00011762033,0.000008636401,7.1684862e-9,0.0000039313077,0.0000049616933,0.00011296234],"study_design_scores_gemma":[0.00045638654,0.00009241994,0.0025175337,0.21478237,0.7816804,0.000020435918,0.00024640336,0.00001587865,1.2502516e-8,0.000012289018,0.000030324314,0.00014555208],"about_ca_topic_score_codex":0.00033526542,"about_ca_topic_score_gemma":0.00054508663,"teacher_disagreement_score":0.72642004,"about_ca_system_score_codex":0.00009688407,"about_ca_system_score_gemma":0.00010765653,"threshold_uncertainty_score":0.9999745},"labels":[],"label_agreement":null},{"id":"W4386046570","doi":"10.1007/s40268-023-00428-4","title":"Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Oral and gingival health research","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tacrolimus; Everolimus; Sirolimus; Medicine; Calcineurin; Dosing; Therapeutic drug monitoring; Adverse effect; Pharmacology; Internal medicine; Ciclosporin; Transplantation; Drug","score_opus":0.21536481290553686,"score_gpt":0.5519977062624285,"score_spread":0.3366328933568916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386046570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010644639,0.9870061,6.05702e-8,0.0019180609,0.0014526881,0.006545556,0.0009826975,0.000112814465,0.0018755724],"genre_scores_gemma":[0.000010025882,0.9723024,0.00001563255,0.0019429761,0.0006770817,0.0013254174,0.0003123375,0.0001790893,0.02323505],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904157,0.0033201962,0.0028786007,0.0008236174,0.0010732788,0.0014885939],"domain_scores_gemma":[0.9940175,0.0024583552,0.0013710699,0.001532878,0.00030151324,0.00031868025],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035209546,0.0007321511,0.0035721073,0.00042572236,0.00042742048,0.000015055731,0.0016128683,0.0012092477,0.0004818533],"category_scores_gemma":[0.0014542672,0.000379076,0.00074155896,0.0050501777,0.00009779715,0.00011206739,0.00090968335,0.005348978,0.000751945],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034403107,0.000077526835,0.000037085425,0.6956304,0.000046294124,0.000018311532,0.00077074865,1.6150631e-8,1.6583478e-7,0.00006919121,0.06522775,0.23808816],"study_design_scores_gemma":[0.00026544888,0.00003924212,0.000043025768,0.41027164,0.00009085128,0.0000031179843,0.000091042246,8.460192e-7,1.2077689e-7,0.000060017202,0.58892345,0.00021117712],"about_ca_topic_score_codex":0.00044589792,"about_ca_topic_score_gemma":0.00010683513,"teacher_disagreement_score":0.5236957,"about_ca_system_score_codex":0.0005571589,"about_ca_system_score_gemma":0.0030023202,"threshold_uncertainty_score":0.9998661},"labels":[],"label_agreement":null},{"id":"W4396608809","doi":"10.1007/s40268-024-00459-5","title":"Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Pharmacodynamics; Pharmacokinetics; Dual (grammatical number); Pharmacology; Medicine; Chemistry; Biochemistry; Signal transduction; Philosophy","score_opus":0.011534756925297913,"score_gpt":0.3250791939346348,"score_spread":0.3135444370093369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396608809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590063,0.0006957387,0.0018757875,0.00003977559,0.0004191424,0.0005403901,0.00007854984,0.000029171746,0.0004208285],"genre_scores_gemma":[0.99836373,0.000064583204,0.0008235861,0.00002611547,0.0004255179,0.00014199827,0.00004264733,0.000048511993,0.00006333089],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99836683,0.000078904566,0.00037624635,0.0005287592,0.00038666636,0.00026259202],"domain_scores_gemma":[0.9995172,0.00001871224,0.00006200102,0.00021310018,0.00012528944,0.00006367126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038752577,0.0002325767,0.00022853135,0.0001564202,0.00005603334,0.00003172071,0.00012645013,0.00008743082,0.00004520278],"category_scores_gemma":[0.0000060294365,0.00021085139,0.0000733994,0.0002970653,0.000070289316,0.000017074071,0.000054865937,0.00029810154,0.000001567288],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013028943,0.0016519885,0.11582634,0.00075018086,0.0012499583,0.0017851952,0.009283781,0.2816019,0.5789535,0.00012995618,0.00035633676,0.00710795],"study_design_scores_gemma":[0.004079099,0.001741317,0.0026507922,0.0002647934,0.00021284672,0.00055694074,0.0020262885,0.9573804,0.030216366,0.00002684846,0.00024591526,0.0005983847],"about_ca_topic_score_codex":0.00008615388,"about_ca_topic_score_gemma":0.0000494666,"teacher_disagreement_score":0.6757785,"about_ca_system_score_codex":0.000107259715,"about_ca_system_score_gemma":0.00032938106,"threshold_uncertainty_score":0.859827},"labels":[],"label_agreement":null},{"id":"W4399384704","doi":"10.1007/s40268-024-00462-w","title":"Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo® Tablets","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Sleep and related disorders","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Somnolence; Postmarketing surveillance; Insomnia; Sleep paralysis; Medicine; Observational study; Suicidal ideation; Adverse effect; Sleep disorder; Psychiatry; Internal medicine; Poison control; Emergency medicine; Injury prevention; Excessive daytime sleepiness","score_opus":0.02254376746278476,"score_gpt":0.3118689907720825,"score_spread":0.2893252233092978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399384704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125046,0.0007140082,0.0000015883599,0.000082643644,0.00025364044,0.00037773352,0.000058271056,0.000009054161,0.007252604],"genre_scores_gemma":[0.99977446,0.00004898936,0.000040595194,0.000014851288,0.000007378606,0.000007083919,0.000037816022,0.000011231209,0.000057586767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998491,0.00018538667,0.0007608802,0.00024409349,0.00018233458,0.00013630759],"domain_scores_gemma":[0.9989107,0.0006909727,0.00014412262,0.00017707753,0.00005805271,0.00001904308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066663703,0.00009225485,0.00024227824,0.00027317365,0.000011438937,0.0000032069115,0.00010040066,0.00009828365,0.000039312174],"category_scores_gemma":[0.00027878236,0.000082034356,0.000027100079,0.0005903726,0.00006394781,0.00004995329,0.000055581986,0.00018276041,0.0000017976544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036666892,0.0057987403,0.8689668,0.00016086607,0.00035604942,0.000013701278,0.09046546,0.0005947625,0.00015998317,0.001682514,0.00049853435,0.027635902],"study_design_scores_gemma":[0.009635021,0.00029403903,0.9820795,0.00030290996,0.00003137159,3.6645858e-7,0.006839731,0.00032840102,0.00001958676,0.00008188263,0.00030470637,0.000082484614],"about_ca_topic_score_codex":0.0011732541,"about_ca_topic_score_gemma":0.00010788812,"teacher_disagreement_score":0.1131127,"about_ca_system_score_codex":0.000020225385,"about_ca_system_score_gemma":0.000030402449,"threshold_uncertainty_score":0.3345264},"labels":[],"label_agreement":null},{"id":"W4402785536","doi":"10.1007/s40268-024-00491-5","title":"Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of General Medical Sciences; National Cancer Institute; University of Pennsylvania; U.S. Department of Veterans Affairs","keywords":"Myeloid leukemia; Myeloid; Sensitivity (control systems); Trametinib; Myeloid cells; Medicine; Cancer research; Internal medicine; Biology; Genetics; Engineering; Signal transduction; MAPK/ERK pathway","score_opus":0.012591918784938701,"score_gpt":0.29009319149394197,"score_spread":0.27750127270900327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402785536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98847026,0.0005745069,0.00029715165,0.004617043,0.0002501396,0.0009819992,0.00018194655,0.0002139539,0.004413008],"genre_scores_gemma":[0.9909743,0.0003768566,0.0012843885,0.0006892421,0.00015018231,0.00017550282,0.00043865084,0.00008325798,0.0058276043],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970153,0.00024414563,0.0005476834,0.00079265836,0.0006647723,0.00073545414],"domain_scores_gemma":[0.9987121,0.00047894169,0.000057793775,0.00048255097,0.000077045544,0.00019152484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010182563,0.0003335439,0.00056806207,0.0006498137,0.000051110448,0.00009430131,0.0001474331,0.00032569584,0.00042987152],"category_scores_gemma":[0.0002559666,0.00030459557,0.0001532383,0.001309896,0.000121374746,0.00022537181,0.0001393093,0.0012359986,0.00048433564],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021312956,0.00126836,0.057996627,0.002339022,0.00075180846,0.0033950822,0.023656253,0.00004617602,0.509776,0.0015335873,0.2082746,0.1888312],"study_design_scores_gemma":[0.017170971,0.00090620236,0.32830825,0.0030977682,0.00051712844,0.00062032806,0.002967478,0.2806592,0.3220878,0.0018119885,0.039621223,0.0022316687],"about_ca_topic_score_codex":0.0007632794,"about_ca_topic_score_gemma":0.00010960193,"teacher_disagreement_score":0.28061303,"about_ca_system_score_codex":0.0022049218,"about_ca_system_score_gemma":0.00078107,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W4404524533","doi":"10.1007/s40268-024-00496-0","title":"In-Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sandoz Canada","keywords":"Relative humidity; Chemistry; Chromatography; Shelf life; Sodium; Humidity; Sodium dodecyl sulfate; Food science; Organic chemistry","score_opus":0.013969203204884036,"score_gpt":0.27798644947447765,"score_spread":0.2640172462695936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404524533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947198,0.0020414237,0.0000068197864,0.0019951018,0.00048915297,0.00033583338,0.00028393607,0.00003053384,0.00009741291],"genre_scores_gemma":[0.99907136,0.000061565865,0.00015058031,0.00030168402,0.00003180692,0.000081501035,0.00007896857,0.000013447241,0.00020905958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984079,0.00026802215,0.0004468881,0.00045229078,0.00005389889,0.00037101356],"domain_scores_gemma":[0.99929523,0.00032940495,0.000043576012,0.0002711938,0.00003657307,0.000024010675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005406609,0.00019527195,0.00043100954,0.00020506748,0.000032908414,0.000017433309,0.00013106807,0.00048747702,0.00048152622],"category_scores_gemma":[0.00014372739,0.00016530693,0.00012386401,0.00046809477,0.00032061376,0.0001740973,0.00012327354,0.0007410679,0.000031054253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011361986,0.00087088736,0.012437275,0.00018149252,0.000050793973,0.000051280334,0.0011622986,0.0000018804071,0.98140633,0.000290962,0.0022763736,0.00013425473],"study_design_scores_gemma":[0.0024104991,0.00008483924,0.046625815,0.00029465242,0.000042636122,0.000012922514,0.00015235275,0.00013993129,0.9450877,0.000935937,0.003920209,0.0002925273],"about_ca_topic_score_codex":0.00008029901,"about_ca_topic_score_gemma":0.00030669,"teacher_disagreement_score":0.036318626,"about_ca_system_score_codex":0.00022313533,"about_ca_system_score_gemma":0.000062832114,"threshold_uncertainty_score":0.6741021},"labels":[],"label_agreement":null},{"id":"W4410829664","doi":"10.1007/s40268-025-00511-y","title":"Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema","year":2025,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"CSL Behring","keywords":"Hereditary angioedema; Medicine; Prophylactic treatment; Term (time); Intensive care medicine; Angioedema; Meta-analysis; Dermatology; Internal medicine","score_opus":0.0998001851149383,"score_gpt":0.3768648895175485,"score_spread":0.2770647044026102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410829664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026719843,0.99355423,0.000040095463,0.000041531894,0.00013951366,0.0031729315,0.00028607494,0.000020374844,0.000073247145],"genre_scores_gemma":[0.019379547,0.9757503,0.00066752615,0.00006072119,0.00020138569,0.0010289085,0.0019331623,0.000049349568,0.00092904683],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976674,0.00016959428,0.0010550934,0.00047599332,0.0003313695,0.00030057074],"domain_scores_gemma":[0.9977184,0.0008707856,0.0007441294,0.00040197792,0.00019305883,0.00007164258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020373966,0.00048887497,0.0054984787,0.0004933176,0.00003988884,0.0000074397985,0.00015112675,0.00022740792,0.00028766607],"category_scores_gemma":[0.000027398528,0.0002739731,0.0028077199,0.0012606217,0.000120069955,0.000043563545,0.000030335512,0.000089915055,8.8975514e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000811214,0.003137431,0.047085445,0.019733736,0.41594312,0.000025688536,0.00061518373,0.00011410006,8.1530594e-8,0.000081904196,0.00023081808,0.5122213],"study_design_scores_gemma":[0.0023115869,0.0015305452,0.024709485,0.0014072421,0.9544173,0.0000014798584,0.000022193857,0.00002743277,0.0000053079543,0.000037689213,0.015179346,0.00035038881],"about_ca_topic_score_codex":0.000030548494,"about_ca_topic_score_gemma":0.000023001734,"teacher_disagreement_score":0.5384742,"about_ca_system_score_codex":0.00012971993,"about_ca_system_score_gemma":0.0002762935,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W4411554374","doi":"10.1007/s40268-025-00514-9","title":"Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Heart and Stroke Foundation; Micropharma (Canada); University of Toronto","funders":"","keywords":"Ivacaftor; Bioequivalence; Medicine; Pharmacology; Pharmacokinetics; Internal medicine","score_opus":0.031276308256390675,"score_gpt":0.38322318267005695,"score_spread":0.3519468744136663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411554374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900388,0.0019753797,0.0022101197,0.0007623309,0.00023136243,0.0017957508,0.000022481365,0.00007741657,0.002886347],"genre_scores_gemma":[0.98402464,0.00017718223,0.014774647,0.00018759829,0.00010383152,0.0003924967,0.000038073966,0.000025914598,0.00027558464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975387,0.00007628113,0.00066005235,0.0005616605,0.00041415932,0.00074917165],"domain_scores_gemma":[0.9980255,0.0011853228,0.00012464347,0.0003796321,0.0001427874,0.00014213655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006782594,0.00022804052,0.00044593512,0.0005466835,0.000108930864,0.000036786987,0.00021414977,0.00015179874,0.000021733917],"category_scores_gemma":[0.001743696,0.00023776155,0.00009246711,0.001140688,0.0000992526,0.0002823333,0.0000683077,0.00039143712,0.000009610481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06310673,0.001423995,0.68586653,0.0065141357,0.00016677135,0.00011548057,0.0020477118,0.001139414,0.04529911,0.02187341,0.0026996522,0.16974707],"study_design_scores_gemma":[0.078595765,0.0053967754,0.702993,0.008763204,0.00015743442,0.000020055586,0.0067707393,0.1340855,0.031989805,0.011974265,0.017498106,0.0017553893],"about_ca_topic_score_codex":0.00023325674,"about_ca_topic_score_gemma":0.000297721,"teacher_disagreement_score":0.16799168,"about_ca_system_score_codex":0.0008081719,"about_ca_system_score_gemma":0.0005235827,"threshold_uncertainty_score":0.9695634},"labels":[],"label_agreement":null},{"id":"W4411698938","doi":"10.1007/s40268-025-00515-8","title":"In-Vitro Comparison of Physical Characteristics, Enzyme Content, and Release Kinetics of Pancreatic Enzyme Preparations Available in Europe and Canada","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pancreatic enzymes; Enzyme; Enzyme kinetics; Kinetics; In vitro; Chemistry; Biochemistry; Food science; Physics","score_opus":0.016392243609865638,"score_gpt":0.27811217942217525,"score_spread":0.2617199358123096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411698938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961182,0.00097413146,0.0000062816493,0.00018145549,0.000033882417,0.0002416752,0.000051181345,0.0000029178154,0.0023903134],"genre_scores_gemma":[0.9987456,0.0001594516,0.00014020533,0.00007629687,0.0000080452855,0.000018568728,0.000034751298,0.0000045872735,0.00081248203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992752,0.00006712478,0.0003181722,0.0001547066,0.0000695462,0.00011522496],"domain_scores_gemma":[0.9995044,0.00018965745,0.00007842781,0.00014135517,0.000050365095,0.0000358131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060115326,0.00008898898,0.0004745655,0.000106116204,0.000009581599,0.0000020168673,0.00002722356,0.000038262857,0.000008230425],"category_scores_gemma":[0.00020558502,0.000083483515,0.000010682855,0.00015920038,0.00010512486,0.00002422925,0.00002776267,0.000111333386,9.571328e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036894987,0.00079647015,0.95343953,0.00023300255,0.00003856413,0.00009927174,0.0011564678,0.000007003388,0.042153966,0.0007024128,0.00073435757,0.0002700288],"study_design_scores_gemma":[0.0029200925,0.00021594326,0.8751831,0.00040486405,0.00012242536,0.000007980851,0.00026411278,0.0019568738,0.11827121,0.00004342492,0.00052684784,0.00008311189],"about_ca_topic_score_codex":0.06799307,"about_ca_topic_score_gemma":0.04969466,"teacher_disagreement_score":0.07825639,"about_ca_system_score_codex":0.00005949067,"about_ca_system_score_gemma":0.000152668,"threshold_uncertainty_score":0.96764594},"labels":[],"label_agreement":null},{"id":"W4416599723","doi":"10.1007/s40268-025-00529-2","title":"Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); Etobicoke General Hospital","funders":"GlaxoSmithKline Biologicals; Vir Biotechnology","keywords":"Pharmacodynamics; Monoclonal antibody; Randomized controlled trial; Intramuscular injection; Clinical trial","score_opus":0.02778996596572109,"score_gpt":0.4006819742762227,"score_spread":0.3728920083105016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416599723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855193,0.00009119314,0.0076751094,0.0018794467,0.00080706103,0.003787855,0.000016624372,0.000029634959,0.00019376376],"genre_scores_gemma":[0.9976323,0.00008724182,0.00061705516,0.0012728743,0.000113349925,0.00018193095,0.000019143281,0.000021247004,0.000054845714],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996124,0.0013974139,0.0012153977,0.00052106945,0.00032809115,0.00041400603],"domain_scores_gemma":[0.9982967,0.00078961614,0.00019070458,0.00038660146,0.00011019178,0.00022619436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037289257,0.000262436,0.0011196487,0.00033184717,0.00010695524,0.000033332406,0.00015464844,0.00017538796,0.000022450351],"category_scores_gemma":[0.0011906215,0.00018511368,0.00026092844,0.0006813318,0.00045493574,0.0000722207,0.00014494329,0.00062339363,0.0000015092888],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93653184,0.0018157371,0.045551628,0.00043019993,0.00049511355,0.000037040812,0.0020341938,0.0050779716,0.0016968255,0.00035774088,0.000056887293,0.005914793],"study_design_scores_gemma":[0.79135495,0.0015464866,0.030803856,0.00039023295,0.00078297465,0.0000279835,0.00020633236,0.1719895,0.0016149273,0.0007216978,0.00024853367,0.0003125295],"about_ca_topic_score_codex":0.0008380105,"about_ca_topic_score_gemma":0.00025339314,"teacher_disagreement_score":0.16691154,"about_ca_system_score_codex":0.00021939391,"about_ca_system_score_gemma":0.00057106564,"threshold_uncertainty_score":0.75487167},"labels":[],"label_agreement":null},{"id":"W4416841363","doi":"10.1007/s40268-025-00530-9","title":"Safety, Tolerability and Pharmacokinetics of a High-Dose, Rapid-Infusion Monoclonal Antibody: Phase I Results for Intravenous Sotrovimab 3000 mg","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline Biologicals; Vir Biotechnology","keywords":"Pharmacokinetics; Tolerability; Monoclonal antibody; Phase (matter); Phases of clinical research","score_opus":0.019543961811636652,"score_gpt":0.3693013937195685,"score_spread":0.34975743190793185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416841363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862097,0.0010830973,0.00040677527,0.0059317783,0.00021335631,0.0011176805,0.00072672026,0.00002754516,0.004283354],"genre_scores_gemma":[0.9928413,0.0017831698,0.0029453773,0.00038036588,0.0001391962,0.000034425117,0.00037499215,0.00001614228,0.0014850395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791694,0.00008960922,0.0007739641,0.00045887168,0.00034136287,0.00041927726],"domain_scores_gemma":[0.9985752,0.0006469758,0.000114816634,0.00029839514,0.00021889547,0.00014568983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007544231,0.00022004328,0.0006374184,0.00029389115,0.00010239287,0.000015203565,0.00015881279,0.00012650905,0.000066393746],"category_scores_gemma":[0.00028941597,0.00018704726,0.00012128338,0.00038191216,0.00028138602,0.000050965424,0.0001796745,0.0003265739,0.0000037300742],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09424089,0.0056125363,0.010081156,0.0036278493,0.0004084345,0.00010479111,0.0025091497,0.000103906175,0.17371143,0.00628775,0.00908204,0.6942301],"study_design_scores_gemma":[0.16108422,0.008746477,0.23792514,0.002525267,0.0006503104,0.00010994967,0.0010913527,0.05620447,0.20512097,0.01453445,0.3106502,0.0013571783],"about_ca_topic_score_codex":0.0005401645,"about_ca_topic_score_gemma":0.000017005877,"teacher_disagreement_score":0.6928729,"about_ca_system_score_codex":0.00008142061,"about_ca_system_score_gemma":0.00030786303,"threshold_uncertainty_score":0.7627566},"labels":[],"label_agreement":null},{"id":"W8127528","doi":"10.2165/00126839-200708060-00003","title":"Improving Early Drug Discovery through ADME Modelling","year":2007,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"ADME; Drug development; Drug discovery; Drug; Risk analysis (engineering); Computer science; Pharmacology; Biochemical engineering; Medicine; Intensive care medicine; Bioinformatics; Engineering; Biology","score_opus":0.08703858291226216,"score_gpt":0.3781868798061028,"score_spread":0.2911482968938407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W8127528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001936663,0.5021253,0.4953457,0.000013644396,0.0007659966,0.00035633307,0.000010441931,0.00009529402,0.0012678945],"genre_scores_gemma":[0.000037577323,0.77830464,0.2205484,0.00008413481,0.0003191683,0.000067439694,0.000029036084,0.00007499855,0.00053462887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99518174,0.0005689567,0.0012663038,0.0013497167,0.0008389579,0.000794342],"domain_scores_gemma":[0.9960051,0.00200401,0.0005762726,0.0012333095,0.00007311543,0.0001081986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020409604,0.00069068186,0.001576492,0.00059111876,0.00011821336,0.00069169287,0.0026182146,0.00028703318,0.0000043210225],"category_scores_gemma":[0.00008606858,0.0006420476,0.0006413253,0.0016721005,0.00007808125,0.002518429,0.0012328787,0.0010920265,0.000114632865],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018822261,0.000051546736,0.0000011080693,0.0024574837,0.00002861119,0.00004095847,0.0011570997,0.020076152,2.6139208e-8,0.03806142,0.000052818086,0.9380709],"study_design_scores_gemma":[0.0002852211,0.00002342588,0.0000036869646,0.009355417,0.00009965599,0.00003879428,0.00004341542,0.21163717,0.0000031101788,0.023330081,0.75373393,0.0014460827],"about_ca_topic_score_codex":0.0004960941,"about_ca_topic_score_gemma":0.000009568084,"teacher_disagreement_score":0.9366248,"about_ca_system_score_codex":0.0004944246,"about_ca_system_score_gemma":0.0007963039,"threshold_uncertainty_score":0.9996031},"labels":[],"label_agreement":null}]}